<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1216492</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>
<italic>Ex vivo</italic> and <italic>in vivo</italic> evidence that cigarette smoke-exposed T regulatory cells impair host immunity against <italic>Mycobacterium tuberculosis</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Bai</surname>
<given-names>Xiyuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/517641"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Verma</surname>
<given-names>Deepshikha</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Garcia</surname>
<given-names>Cindy</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Musheyev</surname>
<given-names>Ariel</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/691106"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Kevin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fornis</surname>
<given-names>Lorelenn</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Griffith</surname>
<given-names>David E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2212689"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Li</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/787607"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Whittel</surname>
<given-names>Nicholas</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2369866"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gadwa</surname>
<given-names>Jacob</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ohanjanyan</surname>
<given-names>Tamara</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eggleston</surname>
<given-names>Matthew J.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galvan</surname>
<given-names>Manuel</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Freed</surname>
<given-names>Brian M.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1889022"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ordway</surname>
<given-names>Diane</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/423930"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Chan</surname>
<given-names>Edward D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/94652"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Academic Affairs, National Jewish Health</institution>, <addr-line>Denver, CO</addr-line>, <country>United States</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Medicine, National Jewish Health</institution>, <addr-line>Denver, CO</addr-line>, <country>United States</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus</institution>, <addr-line>Aurora, CO</addr-line>, <country>United States</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Mycobacteria Research Laboratories, Department of Microbiology, Immunology and Pathology, Colorado State University</institution>, <addr-line>Fort Collins, CO</addr-line>, <country>United States</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Complement Laboratory, Advance Diagnostics, National Jewish Health</institution>, <addr-line>Denver, CO</addr-line>, <country>United States</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Department of Medicine, University of Colorado Anschutz Medical Campus</institution>, <addr-line>Aurora, CO</addr-line>, <country>United States</country>
</aff>
<aff id="aff7">
<sup>7</sup>
<institution>Department of Medicine, Rocky Mountain Regional Veterans Affairs Medical Center</institution>, <addr-line>Aurora, CO</addr-line>, <country>United States</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Smita Kulkarni, Texas Biomedical Research Institute, United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Shashank Ganatra, Oregon Health &amp; Science University, United States; Afsal Kolloli, Rutgers University, Newark, United States; Farzam Vaziri, University of California, Davis, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xiyuan Bai, <email xlink:href="mailto:BaiX@NJHealth.org">BaiX@NJHealth.org</email>; Edward D. Chan, <email xlink:href="mailto:ChanE@NJHealth.org">ChanE@NJHealth.org</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1216492</elocation-id>
<history>
<date date-type="received">
<day>03</day>
<month>05</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>08</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Bai, Verma, Garcia, Musheyev, Kim, Fornis, Griffith, Li, Whittel, Gadwa, Ohanjanyan, Eggleston, Galvan, Freed, Ordway and Chan</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Bai, Verma, Garcia, Musheyev, Kim, Fornis, Griffith, Li, Whittel, Gadwa, Ohanjanyan, Eggleston, Galvan, Freed, Ordway and Chan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>A strong epidemiologic link exists between cigarette smoke (CS) exposure and susceptibility to tuberculosis (TB).  Macrophage and murine studies showed that CS and nicotine impair host-protective immune cells against <italic>Mycobacterium tuberculosis (MTB)</italic> infection.  While CS and nicotine may activate T regulatory cells (Tregs), little is known about how CS may affect these immunosuppressive cells with <italic>MTB</italic> infection.</p>
</sec>
<sec>
<title>Methods</title>
<p>We investigated whether CS-exposed Tregs could exacerbate <italic>MTB</italic> infection in co-culture with human macrophages and in recipient mice that underwent adoptive transfer of Tregs from donor CS-exposed mice.</p>
</sec>
<sec>
<title>Results</title>
<p>We found that exposure of primary human Tregs to CS extract impaired the ability of unexposed human macrophages to control an <italic>MTB</italic> infection by inhibiting phagosome-lysosome fusion and autophagosome formation.  Neutralizing CTLA-4 on the CS extract-exposed Tregs abrogated the impaired control of <italic>MTB</italic> infection in the macrophage and Treg co-cultures.  In Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice depleted of endogenous Tregs, adoptive transfer of Tregs from donor CS-exposed B6.PL(Thy1.1) mice with subsequent <italic>MTB</italic> infection of the Thy1.2 mice resulted in a greater burden of <italic>MTB</italic> in the lungs and spleens than those that received Tregs from air-exposed mice.  Mice that received Tregs from donor CS-exposed mice and infected with <italic>MTB</italic> had modest but significantly reduced numbers of interleukin-12-positive dendritic cells and interferon-gamma-positive CD4<sup>+</sup> T cells in the lungs, and an increased number of total programmed cell death protein-1 (PD-1) positive CD4<sup>+</sup> T cells in both the lungs and spleens.</p>
</sec>
<sec>
<title>Discussion</title>
<p>Previous studies demonstrated that CS impairs macrophages and host-protective T effector cells in controlling <italic>MTB</italic> infection.  We now show that CS-exposed Tregs can also impair control of <italic>MTB</italic> in co-culture with macrophages and in a murine model.</p>
</sec>
</abstract>
<kwd-group>
<kwd>adoptive transfer</kwd>
<kwd>CTLA-4</kwd>
<kwd>macrophage</kwd>
<kwd>autophagy</kwd>
<kwd>T regulatory</kwd>
</kwd-group>
<counts>
<fig-count count="9"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="68"/>
<page-count count="17"/>
<word-count count="10339"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Adaptive immunity in infection</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Worldwide, there are marked geographic overlaps between cigarette smoking and tuberculosis (TB) cases (<xref ref-type="bibr" rid="B39">Pai et&#xa0;al., 2007</xref>). Epidemiological studies show that individuals with cigarette smoke (CS) exposure have increased: infection rate with <italic>Mycobacterium tuberculosis</italic> (<italic>MTB</italic>), progression of primary infection, reactivation TB, severe disease, delay in sputum conversion, recurrence (relapse), worse treatment outcome, and TB mortality (<xref ref-type="bibr" rid="B5">Bishwakarma et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B11">Chiang and Bam, 2020</xref>; <xref ref-type="bibr" rid="B60">Wang et&#xa0;al., 2020</xref>). CS has deleterious effects on anti-TB immunity &#x2013; including: <italic>(i)</italic> impairing macrophage killing of <italic>MTB</italic> by inhibiting phagosome-lysosome fusion, autophagy, efferocytosis, and apoptosis of infected macrophages, all due in part to polarization of macrophages to an immunosuppressive phenotype; <italic>(ii)</italic> decreasing the number of T<sub>H</sub>1 cells and production of interferon-gamma (IFN&#x3b3;) from each cell; and <italic>(iii)</italic> increasing the expression of programmed death-ligand 1 and 2 (PD-L1/2) on antigen-presenting cells, which can lead to T effector cell exhaustion and death (<xref ref-type="bibr" rid="B12">Feng et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B48">Shang et&#xa0;al., 2011b</xref>; <xref ref-type="bibr" rid="B46">Shaler et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B10">Chan et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B35">O&#x2019;Leary et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B56">van Zyl-Smit et&#xa0;al., 2014</xref>). However, the impact of CS on immunoregulating cells, particularly T regulatory cells (Tregs) has been less well studied (<xref ref-type="bibr" rid="B3">Bai et&#xa0;al., 2017</xref>). O&#x2019;Leary et al (<xref ref-type="bibr" rid="B35">O&#x2019;Leary et&#xa0;al., 2014</xref>) reported that both smokers&#x2019; and non-smokers&#x2019; alveolar macrophages could equally induce phenotypic differentiation of Tregs <italic>ex vivo</italic> but the co-culture of alveolar macrophages and na&#xef;ve T cells were allogeneic and required stimulation with anti-CD3 antibody. Nevertheless, the findings from this previous study allude to the possibility that CS may impact immunosuppressive cells, leading to increased susceptibility to TB.</p>
<p>Murine studies have shown that knockdown of Tregs in the <italic>early</italic> phase of <italic>MTB</italic> infection results in reduced bacillus burden, indicating that an excessive number of Tregs soon after infection impairs host immunity against <italic>MTB</italic> (<xref ref-type="bibr" rid="B38">Ozeki et&#xa0;al., 2010</xref>). Moreover, active TB patients have higher Treg numbers than those with latent TB infection (<xref ref-type="bibr" rid="B6">Boer et&#xa0;al., 2015</xref>). Thus, a vigorous early influx of activated Tregs to the lungs, particularly before <italic>MTB</italic> infection is under control, worsens TB in experimental animals and is supported by congruent findings in primary human cells (<xref ref-type="bibr" rid="B36">Ordway et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B45">Shafiani et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B47">Shang et&#xa0;al., 2011a</xref>; <xref ref-type="bibr" rid="B42">Rowe et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B26">Larson et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B44">Semple et&#xa0;al., 2013</xref>).</p>
<p>Previously, our group and others showed that CS and nicotine could impair the ability of macrophages to control an <italic>MTB</italic> infection (<xref ref-type="bibr" rid="B12">Feng et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B48">Shang et&#xa0;al., 2011b</xref>; <xref ref-type="bibr" rid="B46">Shaler et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B10">Chan et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B35">O&#x2019;Leary et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B56">van Zyl-Smit et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B3">Bai et&#xa0;al., 2017</xref>). However, since CS and nicotine may <italic>(i)</italic> increase the influx and function of Tregs in the lungs (<xref ref-type="bibr" rid="B32">M&#xe9;nard and Rola-Pleszczynski, 1987</xref>; <xref ref-type="bibr" rid="B4">Barcel&#xf3; et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B7">Botelho et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B63">Wang et&#xa0;al., 2010</xref>), <italic>(ii)</italic> significantly increase the number of alveolar macrophages (<xref ref-type="bibr" rid="B59">Wallace et&#xa0;al., 1992</xref>), and <italic>(iii)</italic> alveolar macrophages of smokers can drive na&#xef;ve T cells toward the Treg phenotype (<xref ref-type="bibr" rid="B35">O&#x2019;Leary et&#xa0;al., 2014</xref>), it is plausible that CS could indirectly impact host immunity negatively against <italic>MTB</italic> by enhancing Treg activity. While the effects of CS on Treg number or activation in the context of <italic>MTB</italic> infection have not been previously reported, the effects of CS on Tregs have been described with somewhat contradictory findings (<xref ref-type="bibr" rid="B40">Qiu et&#xa0;al., 2017</xref>). On the one hand, several studies have shown that CS and nicotine may increase the number of Tregs and their activity in the lungs of both humans and mice (<xref ref-type="bibr" rid="B32">M&#xe9;nard and Rola-Pleszczynski, 1987</xref>; <xref ref-type="bibr" rid="B52">Smyth et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B4">Barcel&#xf3; et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B21">Isajevs et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B7">Botelho et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B63">Wang et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B49">Shao et&#xa0;al., 2022</xref>). More specifically, CS led to an accumulation of FoxP3<sup>+</sup> Tregs in the lungs of both C57BL/6 and BALB/c mice (<xref ref-type="bibr" rid="B7">Botelho et&#xa0;al., 2010</xref>) as well as in mouse spleens (<xref ref-type="bibr" rid="B49">Shao et&#xa0;al., 2022</xref>). In humans, active smokers &#x2013; &#x201c;healthy&#x201d; individuals and those with chronic obstructive pulmonary disease &#x2013; have increased numbers of Tregs in the lung lavage fluid or in the large airways compared with non- smokers (<xref ref-type="bibr" rid="B52">Smyth et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B21">Isajevs et&#xa0;al., 2009</xref>). On the other hand, others have also found that CS decreased Treg number or function albeit potential confounders for these alternative findings include: <italic>(i)</italic> the presence of underlying chronic obstructive pulmonary disease (in whom these studies are often done); <italic>(ii)</italic> the presence of cell types other than Tregs in the <italic>in vitro</italic> experiments (<italic>e.g.</italic>, CS extract decreased Treg numbers but only in co-culture with dendritic cells (<xref ref-type="bibr" rid="B20">Huang et&#xa0;al., 2021</xref>); and <italic>(iii)</italic> the differential effects of CS on different Treg subpopulations (<xref ref-type="bibr" rid="B34">Miyara et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B40">Qiu et&#xa0;al., 2017</xref>). This last confounder &#x2013; <italic>viz-a-viz</italic> unique Treg subpopulations &#x2013; underscores that the aforementioned discussions on Tregs and TB as well as CS and Tregs are oversimplified since at least three subpopulations of Tregs have been reported: <italic>(i)</italic> resting, suppressive Tregs (rTregs, CD25<sup>+</sup>FoxP3<sup>lo</sup>CD45RA<sup>+</sup>); <italic>(ii)</italic> activated, suppressive Tregs (aTregs, CD25<sup>hi</sup>FoxP3<sup>hi</sup>CD45RA<sup>&#x2013;</sup>); and <italic>(iii)</italic> pro-inflammatory, cytokine-secreting (IFN&#x3b3; and IL-2) Tregs (FrIII, CD25<sup>+</sup>FoxP3<sup>lo</sup>CD45RA<sup>&#x2013;</sup>) (<xref ref-type="bibr" rid="B34">Miyara et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B40">Qiu et&#xa0;al., 2017</xref>).</p>
<p>To further elucidate the effects of CS on anti-TB host immunity, we undertook an <italic>ex vivo</italic> study of co-culture of human macrophages and air- or CS extract-exposed Tregs as well as an <italic>in vivo</italic> murine study using adoptive transfer of Tregs from air- or CS-exposed donor mice to determine whether CS-exposed Tregs could exacerbate <italic>MTB</italic> infection in the recipient mice.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>
<italic>Mycobacterium tuberculosis</italic> strains, mice, and reagents</title>
<p>H37Rv-<italic>MTB</italic> was obtained from American Type Culture Collection (ATCC, Manassas, VA). HN878 W-Beijing strain of <italic>MTB</italic> (HN878-W-Beijing <italic>MTB</italic>) was originally a kind gift from Dr. B. Kreiswirth (Public Health Research Institute Center, Newark, NJ). The B6.PL(Thy1.1) and Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice were purchased from Jackson Laboratories, Bar Harbor, Maine. Cell Preparation Tubes (CPT) used to isolate peripheral blood mononuclear cells (PBMC) were purchased from BD Company (San Jose, CA). The Miltenyi Biotech Regulatory T Cell Isolation Kit II (human) (Auburn, CA) was used to isolate human Tregs from peripheral blood. 4&#x2032;,6-diamidino-2-phenylindole (DAPI) and LysoTracker Red DND-99 were purchased from Invitrogen, Carlsbad, CA. Macrophage colony-stimulating factor (M-CSF, human) was purchased from Millipore Sigma, St. Louis, MO. Fetal bovine serum was acquired from Atlanta Biologicals (Norceross, GA) and inactivated at 56&#xb0;C for one hour. The LC3-IIB and p62 primary rabbit antibodies were purchased from Cell Signaling Technology Inc. (Danvers, MA). Roswell Park Memorial Institute (RPMI) medium, CY3 goat anti-rabbit IgG (H+L) Cross-Adsorbed Secondary Antibody, and the four and eight chambered Nunc&#x2122; Lab-Tek&#x2122; II Chamber Slide&#x2122; System were purchased from ThermoFisher Scientific (Waltham, MA). PE-conjugated anti-CTLA-4 and APC-conjugated anti-CD279 (PD-1) were purchased from R&amp;D System (Minneapolis, MN). Human cytokines from cell culture supernatants were analyzed using ELISA kits for TNF, IL-10, and TGF&#x3b2; (R&amp;D Systems, Minneapolis, MN and Invitrogen-ThermoFisher Scientific, Waltham, MA). Anti-CTLA-4 neutralizing antibody and non-immune human IgG antibody were purchased from BPS Bioscience Inc (San Diego, CA). Diphtheria toxin was purchased from List Biological Laboratories, Campbell, CA. Information on other reagents are discussed in the relevant methods sections below.</p>
</sec>
<sec id="s2_2">
<title>Cigarette smoke extract preparation</title>
<p>CS extract was prepared by mechanically &#x201c;smoking&#x201d; a single unfiltered 3R4F cigarette into 10 mL of pre-warmed RPMI medium via a vacuum pump, with the flow adjusted at 3 L/min using an Accucal flowmeter (Gilmont Instruments). The extract was then filtered through a 0.22 &#xb5;m syringe filter and adjusted to a pH of 7.4. This solution is arbitrarily designated as 100% CS extract (<xref ref-type="bibr" rid="B37">Ouyang et&#xa0;al., 2000</xref>).</p>
</sec>
<sec id="s2_3">
<title>Blood processing and Treg isolation</title>
<p>After informed consent (Colorado Multiple Institutional Board Review, protocol 16-1413), blood was drawn into six Cell Preparation Tubes<sup>&#xae;</sup> from each healthy donor. Peripheral blood mononuclear cells (PBMC) were isolated by centrifugation. Following the determination of the total cell count, half of the PBMC aliquot was cryopreserved in freeze medium (85% FBS, 15% DMSO) for future Treg isolation. The other half was incubated with 20 ng/mL of monocyte-colony stimulating factor for one week to prepare monocyte-derived macrophages (MDM).</p>
<p>One day before completion of MDM differentiation, an autologous cryopreserved PBMC aliquot was thawed and then centrifuged to remove the DMSO. Tregs were isolated from PBMC using the Regulatory T Cell Isolation Kit II according to manufacturer&#x2019;s instructions. In brief, non-CD4<sup>+</sup> and CD127<sup>high</sup> cells were magnetically labeled and then depleted. From the remaining cells, CD25<sup>+</sup> cells were magnetically labeled and then isolated, yielding only cells with biomarkers CD4<sup>+</sup>CD25<sup>+</sup>CD127<sup>dim/-</sup>, the cell surface signature of Tregs.</p>
<p>To confirm that Tregs were isolated, the cells were stained with CD127-BB515, CD25-PE, and CD4-APC-CY7, and analyzed with LSR Fortessa equipped with FACSDiva (BD Biosciences) and with the aid of FlowJo software. As shown in <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;1</bold>
</xref>, essentially all the isolated cells had markers entirely consistent with Tregs.</p>
</sec>
<sec id="s2_4">
<title>MDM infection and co-culture to quantify CFU</title>
<p>Differentiated MDM were infected with <italic>MTB</italic> H37Rv at a multiplicity-of-infection of 10 <italic>MTB</italic>:1 macrophage for one hour, and then washed gently to remove any free <italic>MTB</italic>. MDM were then incubated with: <italic>(i)</italic> RPMI medium + 10% FBS alone or with <italic>(ii)</italic> non-conditioned Tregs or <italic>(iii)</italic> Tregs previously conditioned in 5% CS extract for 18 to 24 hours at a ratio of 100 monocytes: 1 Treg. This ratio is the approximate ratio of lung macrophages:Tregs found in the bronchoalveolar lavage of healthy individuals (<xref ref-type="bibr" rid="B18">Heron et&#xa0;al., 2011</xref>). After an additional hour of incubation, Day 0 cells were washed, lysed, serially diluted, and plated on 7H10 agar to quantify <italic>MTB</italic>. Different aliquots of cells &#x2013; incubated with <italic>MTB</italic> for one hour and then washed &#x2013; were then incubated under the same three aforementioned conditions for 2 or 4 days before quantifying <italic>MTB</italic>.</p>
</sec>
<sec id="s2_5">
<title>Phagosome-lysosome fusion</title>
<p>PBMC were differentiated into MDM in four-chamber glass slides. After one week, the MDM were co-cultured with autologous Tregs (100 MDM:1 Treg ratio) that had been previously cultured in medium alone or with 5% CS extract for 18 to 24 hours. MDM alone and MDM co-cultured with air- or CSE-exposed Tregs were infected with GFP-<italic>MTB</italic> H37Rv at a MOI of 10 <italic>MTB</italic>:1 macrophage for six hours. At the 4-hour mark, 25 &#xb5;L of LysoTracker Red (50 nM) was added to each chamber well containing 500 &#xb5;L of medium to label the lysosomes. At the 6-hour time point, the medium was removed, the cells fixed with 4% paraformaldehyde, washed thrice with 1X PBS, stained with DAPI and stored overnight to dry in the dark at room temperature. The following day, the cells were viewed under 40X oil immersion lens with an inverted Zeiss 200M microscope and a 175-watt xenon lamp in a DG4 Sutter instrument lamp housing. The Cy3 filter was used to detect the LysoTracker-stained lysosomes while FITC was used to detect GFP-<italic>MTB</italic>. Co-localization of the GFP-<italic>MTB</italic> with lysosomes would appear yellow. Ten random pictures were taken per well with Live-Cell Marianis. Images were further analyzed using FIJI software. Phagosome-lysosome (P-L) fusion was calculated by dividing the number of cells with evidence of GFP-<italic>MTB</italic> and lysosome fusion by the total number of cells containing GFP-<italic>MTB</italic>, the latter cell type comprised of at least 100 cells per condition (<xref ref-type="bibr" rid="B1">Bai et&#xa0;al., 2019</xref>).</p>
</sec>
<sec id="s2_6">
<title>Autophagosome formation and maturation</title>
<p>MDM were co-cultured in four-chamber glass slides with Tregs (100 MDM:1 Treg) that were previously exposed to medium alone or 5% CS extract for 18 to 24 hours. After one hour of incubation with Tregs, the cells were infected with GFP-<italic>MTB</italic> (MOI of 10 <italic>MTB</italic>:1 macrophage) and incubated for 18 hours at 37&#xb0;C and 5% ambient CO<sub>2</sub>. The cells were then washed with PBS, fixed with 4% paraformaldehyde for 30 minutes, washed, incubated with permeabilization buffer (0.5% Triton X in PBS) for 10 minutes, rinsed with PBS, and incubated with blocking buffer (5% BSA, 0.5% Tween 20 in PBS) for one hour. Anti-LC3 antibody at a dilution of 1.5:200 was incubated with the cells and left in a dark container at 4&#xb0;C overnight. An anti-rabbit CY3 tagged antibody (1:1000) was added to the wells, left in the dark at room temperature for 45 minutes, and the cells were fixed with DAPI. The slides were dried overnight and viewed with the Live-Cell Marianis microscope to analyze and quantify autophagosome formation. Multiple images were taken from all conditions and five were picked at random. The number of LC3-II-positive puncta per cell was determined and averaged for 150 randomly chosen cells. The same process was replicated for all three conditions.</p>
<p>To determine autophagosome maturation, we quantified p62-positive puncta in a temporal fashion of MDM, MDM + unexposed Tregs, and MDM + CS extract-exposed Tregs that were infected with GFP-<italic>MTB</italic> for 3, 6, and 18 hours. At the end of each time point, the cells were washed with 1X PBS and fixed with 4% paraformaldehyde for 30 minutes. The cells were washed, permeabilized for 10 minutes, rinsed with 1X PBS, and incubated with a blocking buffer for one hour. Lastly, 25 &#xb5;L of anti-p62-rabbit antibody [1:200] was added to each chamber well and incubated overnight at 4&#xb0;C. Then CY3 anti-rabbit [1:1000] secondary antibody was added and incubated for 45 minutes in the dark. After incubation, slides were rinsed, DAPI added, and once dried, the cells were viewed under a 40X oil emersion lens. CY3 filter was used for detecting p62 and FITC for GFP-<italic>MTB</italic>. Further analyses of p62 in the presence of 200 nM rapamycin and 100 nM bafilomycin were conducted similarly.</p>
</sec>
<sec id="s2_7">
<title>CS exposure of mice</title>
<p>The B6.PL(Thy1.1) mice were exposed to CS in a whole animal exposure chamber using smoke generated by the TE-10c cigarette smoking machine (Teague Enterprises) as previously described (<xref ref-type="bibr" rid="B48">Shang et&#xa0;al., 2011b</xref>). The relative proportion of smoke particulate, vapors, and gases generated approximate environmental CS exposure (89% side-stream smoke exposure and 11% mainstream CS exposure), maintaining a Total Suspended Particulate concentration of 85-120 mg/m<sup>3</sup> for 5 hours a day and 5 days a week for four weeks.</p>
</sec>
<sec id="s2_8">
<title>Depleting, harvesting, and adoptively transferring Tregs</title>
<p>Ten days before the adoptive transfer of Tregs, endogenous Tregs of the recipient Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice were depleted via administration of diphtheria toxin at 50 &#xb5;g/kg x four doses intraperitoneally (<xref ref-type="bibr" rid="B16">Henao-Tamayo et&#xa0;al., 2016</xref>). Tregs of the air- and CS-exposed B6.PL(Thy1.1) mice were harvested by cell sorting. To sort CD4<sup>+</sup>CD25<sup>hi</sup>CD127<sup>&#x2212;</sup> and CD4<sup>+</sup>CD25<sup>&#x2212;</sup> cells, single cell suspension was prepared from the spleens of donor B6.PL(Thy 1.1) mice. After incubating with 5 &#xb5;g/mL Fc block (ebioscience) for 20 min at 4&#xb0;C, the cells were attained with APC labeled anti-CD4 (clone gk1.1; ebioscience), Pe Cy7-labeled anti-CD25 (clone PC61.5; ebioscience), Alexa ef450 labeled CD127 (eBioRDR5; ebioscience) and FITC-labeled anti-CD3 (clone 17A2; ebioscience). Thereafter, the cells were stained with 0.5 &#xb5;g/ml 7-AAD (eBioscience) for 5 min, sorted on a FACS Aria III (BD Biosciences) with a 70-&#x3bc;m nozzle, doublets gated out by FSC-A vs. FSC-H, and 7-AAD<sup>+</sup> dead cells excluded from the singlet population using FL3. The live CD4<sup>+</sup>CD25<sup>hi</sup>CD127<sup>&#x2212;</sup> or CD4<sup>+</sup>CD25<sup>&#x2212;</sup> were individually sorted. One million donor Tregs were transferred to each Treg-depleted Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mouse via intravenous tail vein injection.</p>
</sec>
<sec id="s2_9">
<title>Infection of Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice with <italic>MTB</italic>
</title>
<p>Once the Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice received the Tregs from the donor B6.PL(Thy1.1) mice, the recipient mice were infected with HN878 W-Beijing strain of <italic>MTB</italic> using the Glas-Col Aerosol Generator at an inoculum dose of 2x10<sup>6</sup> CFU/mL. The mice were exposed to an aerosol infection in which approximately 100 bacteria were deposited in the lungs of each mouse.</p>
</sec>
<sec id="s2_10">
<title>
<italic>MTB</italic> enumeration in mice</title>
<p>One, 30 and 60 days after infection, the mice were sacrificed by CO<sub>2</sub> inhalation, and their lungs and spleen were prepared to quantify <italic>MTB</italic> (CFU) and immune cell phenotypes by flow cytometry and analyze the lungs by histopathology. The lungs and spleens were homogenized in saline and serial dilutions were plated on 7H11 agar plates supplemented with OADC (BD Biosciences, San Jose, CA). After 3-4 weeks of incubation at 37&#xb0;C, CFUs were quantified and the data were expressed as the log<sub>10</sub> numbers per target organ.</p>
</sec>
<sec id="s2_11">
<title>Flow cytometry for surface markers and intracellular cytokines</title>
<p>For flow cytometric analysis, single-cell suspensions of lungs and spleen from each mouse were resuspended in PBS containing 0.1% sodium azide. Fc receptors were blocked with purified anti-mouse CD16/32. The cells were incubated in the dark for 25 minutes at 4&#xb0;C with predetermined optimal titrations of specific antibodies. Cell surface expression was analyzed with antibodies for CD4 (clone GK1.5), CD11c (clone HL3), CD11b (clone M1/70), PD-1 (CD279) (clone J43), and CTLA-4 (clone 63828; R&amp;D Systems). All antibodies and reagents were purchased from BD Pharmingen (San Diego, CA). The samples were probed using a Becton Dickinson FACSCanto instrument, and the data were analyzed using FlowJo software. Individual cell populations were identified according to the presence of specific fluorescence-labeled antibodies. A total of 300,000 gated events were collected for each sample and gated for each cell phenotype, differentiated by specific antibodies (<xref ref-type="bibr" rid="B17">Henao-Tamayo et&#xa0;al., 2010</xref>).</p>
</sec>
<sec id="s2_12">
<title>Intracellular cytokine staining</title>
<p>The cells were initially stimulated for 4 hours at 37&#xb0;C with a 1X cell stimulation cocktail (eBioscience) diluted in complete DMEM. Thereafter, the cells were stained for cell surface markers, fixed, and permeabilized according to the manufacturer&#x2019;s instructions for the Fix/Perm and Perm wash kit (eBioscience). The cells were then incubated for 30 minutes at 4&#xb0;C with FcBlock plus anti&#x2013;IL-10 (clone JES5-16E3; eBioscience), anti&#x2013;IFN&#x3b3; (clone XMG1.2; eBioscience), anti-Foxp3 (clones FJK-16s; eBioscience), anti-IL-12 (clone C15.6; BD), or anti-TNF (clone MP6-XT22; eBioscience), or with the respective isotype control. Data acquisition was performed on FACSCanto cytometer (BD) and analysis was performed as described (<xref ref-type="bibr" rid="B2">Bai et&#xa0;al., 2015</xref>).</p>
</sec>
<sec id="s2_13">
<title>Statistical analyses</title>
<p>Replicate experiments with duplicate wells for each condition per experiment are independent, and data are presented as means &#xb1; SEM or representative experiment. Group means were compared by repeated-measures ANOVA using Fisher&#x2019;s least significant test or by two-way ANOVA with Bonferroni&#x2019;s <italic>post-hoc</italic> test. Data were graphed in Prism 9<sup>&#xae;</sup> and comparisons were considered significant when p&lt;0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Cigarette smoke extract-exposed T regulatory cells further enhance proliferation of <italic>Mycobacterium tuberculosis</italic> in macrophages</title>
<p>To determine whether CS extract-exposed human Tregs impair macrophage control of <italic>MTB</italic>, MDM were first infected with <italic>MTB</italic> for 1 hour, washed to removed free <italic>MTB</italic>, and then co-cultured with autologous primary human Tregs (at a ratio of 100 monocytes: 1 Treg (<xref ref-type="bibr" rid="B18">Heron et&#xa0;al., 2011</xref>)) that were previously incubated in medium alone or with 5% CS extract for 18-24 hours. It is important to emphasize that the Tregs were washed to remove any medium containing CS extract before co-culture with the MDM to ensure that any effect of CS extract was caused by the CS extract-exposed Tregs and not due to any direct effects of CS extract on MDM. After the <italic>MTB</italic>-infected cell co-cultures were incubated for 1 hour, 2 and 4 days, cell-associated <italic>MTB</italic> were quantified as previously reported (<xref ref-type="bibr" rid="B3">Bai et&#xa0;al., 2017</xref>). As an additional control, MDM without Tregs were also infected with <italic>MTB</italic>. Compared to MDM alone, co-culture of MDM with control Tregs increased the bacterial burden, which further increased in co-culture with CS extract-exposed Tregs (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Cigarette smoke extract-exposed T regulatory cells impair macrophage control of <italic>Mycobacterium tuberculosis</italic> infection by reducing phagosome-lysosome fusion. <bold>(A)</bold> <italic>MTB</italic>-infected human monocyte-derived macrophages (MDM) alone or co-incubated with unexposed or 5% cigarette smoke (CS) extract-exposed T regulatory cells (Tregs) for the indicated times and intracellular <italic>MTB</italic> (CFU) quantified. <bold>(B)</bold> MDM were infected with green fluorescent protein (GFP)-<italic>MTB</italic> alone or co-incubated with unexposed or 5% CS extract-exposed Tregs, and at the indicated times, the percent of cells infected was calculated by dividing the number of GFP-<italic>MTB</italic> infected MDM by the total number of at least 500 MDM cells counted per condition. Data in <bold>(A, B)</bold> represent the mean &#xb1; SEM of experiments of cells performed in duplicates from three subjects. <bold>(C)</bold> <italic>MTB</italic> were cultured in 7H9 medium alone or with the indicated CS extract concentrations for 2 and 4 days and <italic>MTB</italic> quantified. Data in <bold>(C)</bold> represent the mean &#xb1; SEM of experiments of cells performed in duplicates of two experiments. <bold>(D)</bold> MDM were incubated in medium alone or co-cultured with unexposed or 5% CS extract-exposed Tregs, followed by infection with GFP-<italic>MTB</italic> and assayed for phagosome-lysosome (P-L) fusion. Shown are representative images of the identified conditions. <bold>(E)</bold> P-L fusion percentage was calculated by dividing the number of cells with evidence of P-L fusion by the total number of cells of five images (400X) for each condition. Data in <bold>(D, E)</bold> represent the mean &#xb1; SEM of four subjects, each with duplicate wells. *p&lt;0.05, **p&lt;0.01, and ***p&lt;0.001. CFU=colony forming units; GFP=green fluorescent protein; <italic>MTB</italic>=<italic>Mycobacterium tuberculosis</italic>; NS=non-significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g001.tif"/>
</fig>
<p>An alternative approach to assess bacterial burden was employed in which MDM alone, MDM + unexposed Tregs, and MDM + CS extract-exposed Tregs were infected with GFP-<italic>MTB</italic> H37Rv for 1 hour, 2 and 4 days and the percentage of GFP-<italic>MTB</italic>-infected MDM determined by fluorescent microscopy. Compared to MDM alone, co-culture of Tregs with MDM increased the percentage of MDM containing GFP-labeled <italic>MTB</italic>, which further increased with the addition of Tregs that were pre-incubated with CS extract (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). CS extract itself did not directly enhance the growth of <italic>MTB</italic> in the absence of macrophages (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>). We conclude that CS extract-exposed Tregs further enhance proliferation of <italic>MTB</italic> in macrophages.</p>
</sec>
<sec id="s3_2">
<title>Cigarette smoke extract-exposed T regulatory cells inhibit phagosome-lysosome fusion in <italic>Mycobacterium tuberculosis</italic>-infected macrophages</title>
<p>An immune evasive mechanism of <italic>MTB</italic> is the inhibition of phagosome-lysosome (P-L) fusion. To determine whether CS extract-exposed Tregs affect P-L fusion in <italic>MTB</italic>-infected macrophages, MDM were cultured alone or co-cultured with autologous Tregs previously exposed to medium alone or with 5% CS extract for 18-24 hours; this was followed by infection with GFP-<italic>MTB</italic> H37Rv for 6 hours and quantitation of P-L fusion. Compared to GFP-<italic>MTB</italic>-infected MDM alone, co-incubation of MDM with Tregs reduced the co-localization of GFP-<italic>MTB</italic> with lysosomes, with even further decrease when MDM were co-cultured with CS extract-exposed Tregs (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1D, E</bold>
</xref>).</p>
</sec>
<sec id="s3_3">
<title>Cigarette smoke extract-exposed T regulatory cells inhibit autophagosome formation and maturation of <italic>Mycobacterium tuberculosis</italic>-infected macrophages</title>
<p>To quantify autophagosome formation, MDM, MDM + unexposed Tregs, and MDM + CS extract-exposed Tregs infected with <italic>MTB</italic> for 18 hours were immunostained with anti-LC3-II antibody and Cy3-tagged goat anti-rabbit antibody. MDM co-incubated with CS extract-exposed Tregs had significantly fewer LC3-II (+) puncta than MDM alone or MDM + unexposed Tregs (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2A, B</bold>
</xref>). These findings indicate that in the presence of CS extract-exposed Tregs, <italic>MTB</italic>-infected MDM had either decreased autophagosome formation, increased autophagosome-lysosome fusion with degradation of autophagosome content, or both.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Cigarette smoke extract-exposed T regulatory cells decreases autophagosome formation. <bold>(A)</bold> Monocyte-derived macrophages (MDM) were incubated in medium alone or co-cultured with unexposed or cigarette smoke (CS) extract-exposed T regulatory cells (Tregs), followed by infection with green fluorescent protein-labeled <italic>Mycobacterium tuberculosis</italic> (GFP-<italic>MTB</italic>) for 18 hours and assayed for LC3-II expression by immunofluorescence. <bold>(B)</bold> Mean LC3-II positive puncta were calculated by counting the individual puncta of <italic>MTB</italic>-infected MDM (150 cells per condition). <bold>(C)</bold> MDM were incubated in medium alone or co-cultured with unexposed or 5% CS extract-exposed Tregs, followed by infection with GFP-<italic>MTB</italic> for 3, 6 and 18 hours, and assayed for p62 expression by immunofluorescence. Data represent the mean &#xb1; SEM of four independent experiments. <bold>(D)</bold> Mean p62(+) puncta were calculated by counting the individual puncta of <italic>MTB</italic>-infected MDM (50 cells per condition). Data represent the mean &#xb1; SEM of three independent experiments, each with duplicate wells. **p&lt;0.01 and ***p&lt;0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g002.tif"/>
</fig>
<p>To analyze which of these two autophagic processes is more dominant in MDM + CS extract-exposed Tregs, expression of the cargo protein sequestosome-1 (p62) &#x2013; located within autophagosomes and degraded upon fusion with lysosomes &#x2013; was temporally quantified. MDM, MDM + unexposed Tregs, and MDM + CS extract-exposed Tregs infected with <italic>MTB</italic> for 3, 6, and 18 hours were immunostained for p62. With MDM alone, there was a modest decrease in p62(+) autophagosomes with increasing time of infection, suggesting increased autophagosome-lysosome fusion (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C, D</bold>
</xref>, open bars). However, in the presence of either unexposed Tregs or CS extract-exposed Tregs, the number of p62(+) autophagosomes did not decrease but there was a modest increase, suggesting a component of blockade in autophagosome-lysosome fusion in the presence of Tregs. Examination of the 18-hour time point shows a modest stepwise increase in p62(+) autophagosomes with MDM, MDM + unexposed Tregs, and MDM + CS extract-exposed Tregs (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>, last three bars), indicating decreased autophagosome-lysosome fusion in the presence of Tregs, especially those that were exposed to CS extract.</p>
<p>To further validate these findings, we quantified p62(+) puncta in the MDM, MDM + unexposed Tregs, and MDM + CS extract-exposed Tregs at 18 hours after infection with <italic>MTB</italic> in the presence of rapamycin, a known inducer of autophagy (<xref ref-type="bibr" rid="B22">Ko et&#xa0;al., 2017</xref>). As previously shown, there was a successive increase in p62 puncta with MDM alone, MDM + unexposed Tregs, and MDM + CS extract-exposed Tregs (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>, open bars). In contrast, in MDM plus either unexposed or CS extract-exposed Tregs treated with rapamycin, there was no increase in p62(+) puncta compared to cells not treated with rapamycin (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>, compare gray bars vs. respective open bars). Because rapamycin did not increase the number of autophagosomes in co-culture of MDM + CS extract-exposed Tregs, it suggests CS extract-exposed Tregs are inhibiting the signaling pathway that leads to autophagosome formation at a site &#x201c;downstream&#x201d; to where rapamycin is augmenting autophagosome formation (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Cigarette smoke extract-exposed T regulatory cells decreases autophagosome formation at a site distal to rapamycin induction of autophagosomes. <bold>(A)</bold> Monocyte-derived macrophages (MDM) were incubated in medium alone or co-cultured with unexposed Tregs or cigarette smoke (CS) extract-exposed Tregs &#xb1; rapamycin or bafilomycin [100 nM] for 18 hours, followed by quantifying p62 expression by immunofluorescence. <bold>(B)</bold> Mean p62 puncta for a total of 50 cells per condition for the indicated conditions. <bold>(C)</bold> Based on the results, we hypothesize that CS extract inhibits autophagy at a site distal to where rapamycin induces autophagosome formation. Data represent the mean &#xb1; SEM of three independent experiments, each with duplicate wells. The four different colored starbursts in the representative crucial immunofluorescent photomicrographs in <bold>(A)</bold> correspond to those shown in the bar graphs in <bold>(B)</bold>. *p&lt;0.05, **p&lt;0.01, and ****p&lt;0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g003.tif"/>
</fig>
<p>To determine whether CS extract-exposed Tregs are inducing autophagosome-lysosome fusion (= autophagosome maturation) to account for the decreased LC3-II(+) autophagosomes, we performed the aforementioned p62 assay in the absence or presence of bafilomycin, which inhibits both lysosome acidification and autophagosome-lysosome fusion (<xref ref-type="bibr" rid="B31">Mauvezin and Neufeld, 2015</xref>). We hypothesized that if CS extract-exposed Tregs were inducing autophagosome-lysosome fusion, then in the presence of bafilomycin, we would expect a relative increase in the number of p62(+) puncta because bafilomycin would be inhibiting the degradation of p62(+) autophagosomes. Unexpectedly, addition of bafilomycin decreased the number of p62(+) puncta, especially in MDM + 5% CS extract-exposed Tregs (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>, last open vs. black bars). However, the size of the p62(+) puncta with bafilomycin treatment were noticeably larger than seen in MDM without bafilomycin treatment, suggesting autophagosome aggregation (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>). Using FIJI software, the p62(+) puncta were measured by area and fluorescence using a Corrected Total Cell Fluorescence equation provided by Luke Hammond from The University of Queensland, Australia (<xref ref-type="bibr" rid="B15">Hammond, 2014</xref>). These analyses showed that the total area fluorescence of the p62(+) puncta were not significantly different with or without bafilomycin (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figures&#xa0;2B, C</bold>
</xref>). These findings support the paradigm that co-incubation of MDM with CS-exposed Tregs reduces autophagosome number by inhibiting their formation (as noted by decreased LC3-II autophagosomes) but also a component of decreased autophagosome maturation (as noted by increased p62(+) marker to the autophagosomes).</p>
</sec>
<sec id="s3_4">
<title>Cytokine expression in <italic>Mycobacterium tuberculosis</italic>-infected macrophages with or without co-culture with unexposed and cigarette smoke extract-exposed T regulatory cells</title>
<p>The supernatant of the MDM, MDM + unexposed Tregs, and MDM + CS extract-exposed Tregs used to obtain the aforementioned <italic>MTB</italic> CFU were saved and assayed for tumor necrosis factor (TNF), interleukin-10 (IL-10), and transforming growth factor-beta (TGF&#x3b2;). Compared to MDM alone, co-culture with unexposed Tregs modestly decreased TNF and increased IL-10 and TGF&#x3b2; at 2 and 4 days after culture (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A-C</bold>
</xref>). Co-culture of MDM with Tregs exposed to CS extract further decreased TNF level and increased levels of IL-10 and TGF&#x3b2; (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4A-C</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Cytokine expression by <italic>Mycobacterium tuberculosis</italic>-infected macrophages &#xb1; unexposed or cigarette smoke extract-exposed T regulatory cells. Monocyte-derived macrophages (MDM) and T regulatory cells (Tregs) were prepared from four different donors. Unexposed or cigarette smoke (CS) extract-exposed Tregs were added to MDM infected with <italic>MTB</italic>. These co-cultures and MDM alone infected with <italic>MTB</italic> were cultured for 1 hour, 2 and 4 days and the supernatants were obtained and measured for <bold>(A)</bold> TNF, <bold>(B)</bold> IL-10, and <bold>(C)</bold> TGF&#x3b2;. Data shown are mean &#xb1; SEM of four independent experiments with each performed in duplicate wells. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. <italic>MTB</italic>=<italic>Mycobacterium tuberculosis</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g004.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Cigarette smoke extract induction of CTLA-4 on T regulatory cells impairs macrophage control of <italic>Mycobacterium tuberculosis</italic> infection</title>
<p>In human lungs, CS exposure promotes Treg function (<xref ref-type="bibr" rid="B32">M&#xe9;nard and Rola-Pleszczynski, 1987</xref>; <xref ref-type="bibr" rid="B4">Barcel&#xf3; et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B63">Wang et&#xa0;al., 2010</xref>). A plausible mechanism by which this occurs is the ability of CS to induce PD-L1/2 on antigen presenting cells, resulting in increased engagement to PD-1 on Tregs (<xref ref-type="bibr" rid="B13">Francisco et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B65">Yanagita et&#xa0;al., 2012</xref>); <italic>i.e.</italic>, whereas engagement of PD-1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on T cells to PD-L1/2 and B7 on macrophages, respectively, inhibits the activity of Foxp3-negative T effector cells, these same molecular interactions enhance the suppressive activity of Tregs (<xref ref-type="bibr" rid="B43">Saresella et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B10">Chan et&#xa0;al., 2014</xref>). Thus, to determine whether PD-1 and/or CTLA-4 plays a mechanistic role by which CS extract-exposed Tregs impair macrophage control of <italic>MTB</italic> infection, we first exposed Tregs to CS extract for 18 hours and quantified PD-1 and CTLA-4 expression. CS extract increased the expression of CTLA-4 but not PD-1 in primary human Tregs (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Cigarette smoke extract induction of CTLA-4 in T regulatory cells increases their ability to impair macrophage control of <italic>Mycobacterium tuberculosis</italic>. <bold>(A)</bold> Unexposed or cigarette smoke (CS) extract-exposed T regulatory cells (Tregs) of a healthy subject were stained with PE-conjugated anti-CTLA-4 and APC-conjugated anti-CD279 (PD-1) and flow cytometry was performed. <bold>(B)</bold> Monocyte-derived macrophages (MDM) infected with <italic>MTB</italic> were cultured alone or co-cultured with unexposed or CS extract-exposed Tregs &#xb1; anti-CTLA-4 or non-immune IgG for 1 hour, 2, and 4 days. After the indicated times, intracellular <italic>MTB</italic> was quantified. The mean &#xb1; SEM of cells derived from four different donors and performed in duplicates are shown. <bold>(C-E)</bold> Human MDM and T regulatory cells (Tregs) were prepared from three different donors. MDM infected with <italic>MTB</italic> were cultured alone or co-cultured with unexposed or CS extract-exposed Tregs &#xb1; anti-CTLA-4 or non-immune IgG for 1 hour, 2, and 4 days and the supernatants were obtained and measured for <bold>(C)</bold> TNF, <bold>(D)</bold> IL-10, and <bold>(E)</bold> TGF&#x3b2;. Data shown are mean &#xb1; SEM of three independent experiments with each performed in duplicate wells. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. <italic>MTB</italic>=<italic>Mycobacterium tuberculosis</italic>; NS=non-significant.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g005.tif"/>
</fig>
<p>To determine the role CS extract-induced CTLA-4 on Tregs may play in impairing MDM control of <italic>MTB</italic>, we incubated CS extract-exposed Tregs with 5 &#xb5;g/mL non-immune IgG or with 5 &#xb5;g/mL anti-CTLA-4 antibody before combining the Tregs with <italic>MTB</italic>-infected MDM (<xref ref-type="bibr" rid="B29">Machicote et&#xa0;al., 2018</xref>). As shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>, macrophages co-cultured with CS extract-exposed Tregs have greater <italic>MTB</italic> burden than MDM alone or MDM + unexposed Tregs. However, in the presence of an anti-CTLA-4 neutralizing antibody, there was a partial but significant abrogation of the increase in <italic>MTB</italic> burden in co-culture of MDM + CS extract-exposed Tregs; such abrogation was not seen with non-immune IgG. These findings indicate that CS extract induction of CTLA-4 on Tregs is a mechanism by which CS extract-exposed Tregs impair macrophage control of <italic>MTB</italic> infection.</p>
<p>The supernatant of the MDM, MDM + unexposed Tregs, MDM&#xa0;+ CS extract-exposed Tregs, and MDM + CS extract-exposed Tregs incubated with IgG or anti-CTLA-4 (and all infected with <italic>MTB</italic>) were assayed for TNF, IL-10, and TGF&#x3b2;. As previously seen, compared to MDM alone, co-culture with unexposed Tregs modestly decreased TNF and increased IL-10 and TGF&#x3b2; at 2 and 4 days after culture (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5C-E</bold>
</xref>). Co-culture of MDM with Tregs exposed to CS extract further decreased TNF level and increased IL-10 and TGF&#x3b2;. Compared to MDM + CS extract-exposed Tregs, neutralization of CTLA-4 significantly abrogated the reduction in TNF at Day 2 after <italic>MTB</italic> infection (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>) and abrogated the increase in IL-10 at Day 2 and TGF&#x3b2; at Day 4 after <italic>MTB</italic> infection (<xref ref-type="fig" rid="f5">
<bold>Figures&#xa0;5D, E</bold>
</xref>).</p>
</sec>
<sec id="s3_6">
<title>Adoptive transfer of T regulatory cells from cigarette smoke-exposed mice increased <italic>Mycobacterium tuberculosis</italic> burden in recipient mice</title>
<p>Tregs in the Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice were depleted by administration of four doses of diphtheria toxin (DT) as we previously reported, wherein ~6-fold depletion of Tregs were achieved in the lungs and &gt;10-fold depletion of Tregs in the spleen (<xref ref-type="bibr" rid="B16">Henao-Tamayo et&#xa0;al., 2016</xref>). In this study, we used higher amounts of DT for the last two doses. Following the adoptive transfer of Tregs from air-exposed and CS-exposed B6.PL(Thy1.1) donor mice into Treg depleted Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice, the latter recipient mice were infected with HN878-W-Beijing <italic>MTB</italic> for 1, 30, and 60 days. Because these mouse strains possess an immunocompetent phenotype, a hypervirulent strain of <italic>MTB</italic> was chosen to achieve a productive infection. Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice in which no Treg depletion or transfer was performed were also infected with HN878 <italic>MTB</italic> as an additional control. The lungs and spleen were harvested, processed, and the CFU of the organs were determined at the indicated times. Compared to control mice and mice that received Tregs from air-exposed mice, those that received Tregs from CS-exposed mice had significantly greater CFU in the lungs and spleens at Day 60 after infection (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Mice receiving T regulatory cells from cigarette smoke-exposed mice have greater burden of <italic>Mycobacterium tuberculosis</italic> in the lungs and spleen. <bold>(A)</bold> T regulatory cells (Tregs) were isolated from two groups of Thy1.1 mice; one group was exposed to cigarette smoke (CS), while the other was exposed to ambient air. The isolated Tregs from unexposed and CS-exposed Thy1.1 mice were adoptively transferred into the recipient, Treg-depleted Thy1.2 mice. A third group of control mice did not undergo Treg depletion or adoptive transfer. All three groups of mice were then infected with <italic>MTB</italic> HN878. The mice from each group were sacrificed at the one, 30 and 60 days after infection. The lungs of mice were homogenized to quantify CFU. <bold>(B)</bold> The spleens of mice were also homogenized to determine CFU. Representative histopathologic photomicrograph (H&amp;E and acid-fast stains) are shown of <bold>(C)</bold> control mice that were infected with <italic>MTB</italic> alone and recipient mice that had previously received Tregs from <bold>(D)</bold> air- or <bold>(E)</bold> CS-exposed mice and then infected with <italic>MTB</italic>. Data shown are the mean &#xb1; SEM of cells derived from five mice. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. <italic>MTB</italic>=<italic>Mycobacterium tuberculosis</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g006.tif"/>
</fig>
</sec>
<sec id="s3_7">
<title>Lung histopathology of mice that received T regulatory cells from cigarette smoke-exposed mice revealed larger, less-discrete lung lesions</title>
<p>Histopathology of the lungs was analyzed at 1, 30 and 60 days after HN878 <italic>MTB</italic> infection. Compared to control mice and mice recipient of Tregs from air-exposed donors, mice that received Tregs from CS-exposed donors demonstrated increased size and number of granuloma-like lesions, increased granulocyte infiltration, and the presence of acid-fast bacilli, particularly in the lesions (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6C&#x2013;E</bold>
</xref>, arrows).</p>
</sec>
<sec id="s3_8">
<title>Immunophenotyping of murine lung macrophages and dendritic cells</title>
<p>Lung macrophages and dendritic cells (DC) of uninfected mice, control <italic>MTB</italic>-infected mice, and Foxp3<sup>+</sup>GFP<sup>+</sup>DTR<sup>+</sup> (Thy1.2) mice that received air- or CS-exposed Tregs followed by <italic>MTB</italic> infection were immunophenotyped for intracellular TNF, IL-12, and IL-10 at 1, 30 and 60 days after <italic>MTB</italic> infection. Compared to no infection, <italic>MTB</italic> infection increased the number of TNF<sup>+</sup> lung macrophages and DC at 30 and 60 days after infection (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7A, B</bold>
</xref>). At 60 days after infection, there was decreased number of TNF<sup>+</sup> macrophages in mice transferred Tregs from CS-exposed mice although this did not reach statistical significance (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7A</bold>
</xref>). At 60 days post infection, there was also a trend toward decreased TNF<sup>+</sup> DC in mice transferred Tregs from either air- or CS-exposed mice (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7B</bold>
</xref>).</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Intracellular cytokine analysis of murine lung macrophages and DCs. Lung macrophages and dendritic cells from uninfected mice, <italic>MTB</italic>-infected mice, and <italic>MTB</italic>-infected mice with adoptive transfer of T regulatory cells (Tregs) from either air-exposed or CS-exposed mice were stained for <bold>(A/B)</bold> TNF, <bold>(C/D)</bold> IL-12, and <bold>(E/F)</bold> IL-10. Data shown are the mean &#xb1; SEM of cells derived from five mice. For the &#x201c;no infection, no Treg transfer&#x201d; condition, there was only one mouse used. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, ****p&lt;0.0001. <italic>MTB</italic>=<italic>Mycobacterium tuberculosis</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g007.tif"/>
</fig>
<p>Compared to uninfected mice, <italic>MTB</italic> infection alone increased the number of IL-12<sup>+</sup> lung macrophages, which further increased with the transfer of either air- or CS-exposed Tregs at 30 days post-infection (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). Interestingly, at 60 days post-infection, IL-12<sup>+</sup> lung macrophages decreased to levels even lower than at 1 day after infection. In contrast, IL-12<sup>+</sup> DC progressively increased temporally with all three <italic>MTB</italic>-infected conditions (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>); in mice that received Tregs from CS-exposed mice, there was a significantly lower number of IL-12<sup>+</sup> DC compared to uninfected mice, mice only infected with <italic>MTB</italic>, or mice that received Tregs from air-exposed mice and then infected with <italic>MTB</italic> (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7D</bold>
</xref>).</p>
<p>There was a temporal increase of IL-10<sup>+</sup> lung macrophages and DC with <italic>MTB</italic> infection (except for DC at Day 30 after infection) (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7E, F</bold>
</xref>). Mice that received Tregs from either air- or CS-exposed mice have decreased IL-10<sup>+</sup> macrophages at Day 60 compared to <italic>MTB</italic>-infected mice without Treg transfer (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>). In contrast, mice that received either air- or CS-exposed Tregs and <italic>MTB</italic>-infected have marked infiltration with IL-10<sup>+</sup> DC at Day 30 compared to mice infected with <italic>MTB</italic> only, but this difference was lost at Day 60 (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7F</bold>
</xref>).</p>
<p>While CTLA-4 is canonically expressed on T cells, it is also present on human monocytes and mature monocyte-derived DC following stimulation with lipopolysaccharide, poly:IC, and various cytokines; CTLA-4 on DC also inhibits CD4<sup>+</sup> T cell proliferation via CTLA-4-mediated production of IL-10 by the DC (<xref ref-type="bibr" rid="B27">Laurent et&#xa0;al., 2010</xref>). Thus, we quantified CTLA-4 expression in the mouse lungs and found that with <italic>MTB</italic> infection, there was a temporal increase in CTLA-4<sup>+</sup> macrophages with <italic>MTB</italic> infection with or without Treg transfer (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). However, in the mice that received air-exposed Tregs, there was a lower amount of CTLA-4<sup>+</sup> macrophages at Day 60, but in the mice that received Tregs from CS-exposed mice, there was higher number of CTLA-4<sup>+</sup> macrophages (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>). There was also a temporal increase of CTLA-4<sup>+</sup> DC with all infections &#x2013; except for Day 30 with the only <italic>MTB</italic>-infected mice (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>). In contrast to that seen with lung macrophages, there was a significant decrease of CTLA-4<sup>+</sup> DC in the mice that received Tregs from CS-exposed mice at Day 60 compared to mice with <italic>MTB</italic> infection alone. We conclude that in mice that received Tregs from CS-exposed mice, there was greater decrease in the number of TNF<sup>+</sup> macrophages, IL-12<sup>+</sup> DC, and CTLA-4<sup>+</sup> DC in the lungs compared to that seen in control mice that either received no Tregs or air-exposed Tregs.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>CTLA-4 expression in the lung macrophages and dendritic cells of the recipient mice. At the indicated times, uninfected mice, after <italic>MTB</italic>-infected Thy1.2 mice, and mice that received T regulatory cells (Tregs) from either air- or cigarette smoke (CS)-exposed Thy1.1 mice and subsequently infected with <italic>MTB</italic> were sacrificed and CTLA-4<sup>+</sup> lung <bold>(A)</bold> macrophages and <bold>(B)</bold> dendritic cells were quantified by flow cytometry. Data shown are the mean &#xb1; SEM of cells derived from five mice. For the &#x201c;no infection, no Treg transfer&#x201d; condition, there was only one mouse used. *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001. <italic>MTB</italic>=<italic>Mycobacterium tuberculosis</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g008.tif"/>
</fig>
</sec>
<sec id="s3_9">
<title>Immunotyping of murine lung CD4<sup>+</sup> T cells</title>
<p>The general gating strategy for T cells is shown in <xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9A</bold>
</xref>. Examining the phenotypic subsets of T cells revealed a temporal increase in CD4<sup>+</sup>IFN&#x3b3;<sup>+</sup> T cells in the lungs of all three mouse groups infected with <italic>MTB</italic> compared to uninfected mice (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9B</bold>
</xref>). But at Day 60, the number of CD4<sup>+</sup>IFN&#x3b3;<sup>+</sup> T cells in mice that received Tregs from CS-exposed mice and infected with <italic>MTB</italic> was less than all other mouse groups but these differences were not statistically significant (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9B</bold>
</xref>, last bar vs. preceding two bars at Day 60).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Cytokine expression of T cells in the lungs of mice that received adoptive transfer of T regulatory cells. <bold>(A)</bold> General gating strategy for T cells in the murine lungs. <bold>(B)</bold> CD4<sup>+</sup>IFN&#x3b3;<sup>+</sup> T cells, <bold>(C)</bold> CD4<sup>+</sup>IL-1<sup>+</sup> T cells, and <bold>(D)</bold> CD4<sup>+</sup>PD-1<sup>+</sup> T cells were quantified in the lungs of the uninfected mice, <italic>MTB</italic>-infected mice, and Thy1.2 mice that received T regulatory cells (Tregs) from air- or cigarette smoke (CS)-exposed Thy1.1 mice and then infected with <italic>MTB</italic>. <bold>(E)</bold> Thy1.1 CD4<sup>+</sup>IFN&#x3b3;<sup>+</sup> transferred Tregs quantified in the lungs of the recipient Thy1.2 mice at the indicated times. Data shown are the mean &#xb1; SEM of cells derived from five mice. For the &#x201c;no infection, no Treg transfer&#x201d; condition, there was only one mouse used. *p&lt;0.05, ***p&lt;0.001, and ****p&lt;0.0001. <italic>MTB</italic>=<italic>Mycobacterium tuberculosis</italic>.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1216492-g009.tif"/>
</fig>
<p>Compared to uninfected mice, the number of CD4<sup>+</sup>IL-1<sup>+</sup> T cells increased temporally in the other mouse groups infected with <italic>MTB</italic> (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9C</bold>
</xref>). While the number of CD4<sup>+</sup>IL-1<sup>+</sup> T cells were similar at Days 1 and 30 between all three groups of <italic>MTB</italic>-infected mice, by Day 60 the mice that received air-exposed Tregs had the least number of IL-1<sup>+</sup>CD4<sup>+</sup> T cells (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9C</bold>
</xref>). In examining an exhaustion marker of CD4<sup>+</sup> T cells, mice that received Tregs from CS-exposed, <italic>MTB</italic>-infected mice had significantly more PD-1-positive T cells at Day 60 (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9D</bold>
</xref>, last bar vs. preceding two bars at Day 60). However, there was no difference in the expression of either PD-1 or CTLA-4 donor Thy1.1<sup>+</sup>Tregs from unexposed or CS-exposed mice in the lungs of the recipient mice at 1, 30, or 60 days after infection (data not shown).</p>
<p>Quantifying the total number of CD4<sup>+</sup> Tregs in the four groups of mice (uninfected, <italic>MTB</italic>-infected alone, and <italic>MTB</italic>-infected mice recipient of Tregs from air- or CS-exposed mice), we found that compared to uninfected mice, <italic>MTB</italic>-infected mice had significantly more total Tregs, which peaked at Day 30 after infection (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>). While there was a lower number of total CD4<sup>+</sup> Tregs at Day 30 after infection in the mice that received Tregs from CS-exposed mice, this was not statistically significant. Similarly, there was a trend of increased number of CD4<sup>+</sup>IL-10<sup>+</sup> Tregs at Day 60 after <italic>MTB</italic> infection in the mice that received Tregs from either air- or CS-exposed mice (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). Since a small population of Tregs can produce IFN&#x3b3; (<xref ref-type="bibr" rid="B68">Zhao et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B23">Koenecke et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B53">Sumida et&#xa0;al., 2018</xref>), we analyzed the population of transferred Thy1.1<sup>+</sup>CD4<sup>+</sup>IFN&#x3b3;<sup>+</sup> Tregs from the air- or CS-exposed Thy1.1 mice in the lungs of the recipient Thy1.2 mice following <italic>MTB</italic> infection. While there was no difference in the population of these Tregs in the lungs at Day 1 or 30, by Day 60 the recipient Thy1.2 mice had fewer donor Thy1.1<sup>+</sup>IFN&#x3b3;<sup>+</sup> Tregs from the CS-exposed mice compared to that from the air-exposed mice (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9E</bold>
</xref>). Furthermore, the temporal increase in the donor CD4<sup>+</sup>IFN&#x3b3;<sup>+</sup> Tregs indicates replication of these donor Tregs in the recipient mice over the course of the infection as previously reported (<xref ref-type="bibr" rid="B16">Henao-Tamayo et&#xa0;al., 2016</xref>).</p>
</sec>
<sec id="s3_10">
<title>Immunophenotyping of murine splenic macrophages, dendritic cells, and T cells</title>
<p>Splenic macrophages and DC were also analyzed 2, 30, and 60 days after <italic>MTB</italic> infection in the three mouse groups. Uninfected mice also served as an additional control. Compared to uninfected mice, the three <italic>MTB</italic>-infected mouse groups demonstrated an increase in intracellular TNF<sup>+</sup>, IL-12<sup>+</sup>, and IL-10<sup>+</sup> macrophages (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figures&#xa0;4A-C</bold>
</xref>) and DC (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;4D-F</bold>
</xref>). With the time points examined, the number of such macrophage and DC phenotypes were highest at 60 days after <italic>MTB</italic> infection except for the IL-12<sup>+</sup> macrophages, which peaked at Day 30 (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;4B</bold>
</xref>). Similarly, the three mouse groups infected with <italic>MTB</italic> had similar numbers of CTLA-4<sup>+</sup> macrophages (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;4G</bold>
</xref>) and dendritic cells (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;4H</bold>
</xref>), with both cell type numbers highest at 60 days after infection.</p>
<p>Analysis of the total number of splenic CD4<sup>+</sup> T cell subsets revealed that, compared to uninfected mice, the number of T cells significantly increased at 30 and 60 days in the three mouse groups that were infected with <italic>MTB</italic> (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;5</bold>
</xref>). More specifically, the total number of IFN&#x3b3;<sup>+</sup> T cells increased progressively from Day 2 to Day 60 after infection in control mice that were only infected with <italic>MTB</italic> and in <italic>MTB</italic>-infected mice that received Tregs from air-exposed mice. In contrast, the temporal increase in the number of IFN&#x3b3;<sup>+</sup> T cells was attenuated in the animals that received Tregs from CS-exposed mice (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;5A</bold>
</xref>
<bold>, last bar vs. preceding two bars at Day 60</bold>). Similarly, compared to uninfected mice, there was an increase in the number of IL-1<sup>+</sup> T cells in the three mouse groups infected with <italic>MTB</italic> (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;5B</bold>
</xref>). The number of such IL-1<sup>+</sup> T cells peaked at Day 30 in the mice infected with <italic>MTB</italic> alone and mice that received Tregs from air-exposed mice whereas they peaked at Day 60 in the mice that received Tregs from CS-exposed mice and subsequently infected with <italic>MTB</italic> (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;5B</bold>
</xref>). In examining the CD4<sup>+</sup> T cell subset expressing the PD-1 exhaustion marker, there was a progressive temporal increase in all three groups of mice infected with <italic>MTB</italic> (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;5C</bold>
</xref>). However, there was significantly greater number of PD-1<sup>+</sup> splenic T cells in the <italic>MTB</italic>-infected mice that received Tregs from CS-exposed mice (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;5C</bold>
</xref>).</p>
<p>In analyzing the splenic Tregs, there was an increased in the total number at Days 30 and 60 in the three mouse groups infected with <italic>MTB</italic> compared to uninfected mice (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;5D</bold>
</xref>). Compared to <italic>MTB</italic> infection alone, those that received air-exposed mice had a robust rise in Tregs at Day 30, which decreased to near basal levels at Day 60. In contrast, there was a progressive increase in Tregs in mice that received Tregs from CS-exposed mice. The number of IL-10<sup>+</sup> Tregs temporally quantified in the spleen followed a very similar pattern to that observed with the total number of Tregs (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;5E</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>While robust epidemiologic evidence shows that CS exposure is significantly associated with the development of active TB and with greater severity (<xref ref-type="bibr" rid="B5">Bishwakarma et&#xa0;al., 2015</xref>), less is known of the mechanisms by which this link occurs. CS has been shown to polarize macrophages toward the M2/deactivated phenotype and to impair macrophage control of <italic>MTB</italic> (<xref ref-type="bibr" rid="B50">Shaykhiev et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B48">Shang et&#xa0;al., 2011b</xref>; <xref ref-type="bibr" rid="B35">O&#x2019;Leary et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B56">van Zyl-Smit et&#xa0;al., 2014</xref>). Previous studies of mice exposed to CS and subsequently infected with <italic>MTB</italic> demonstrated similarly decreased influx of host-protective cells, particularly IFN&#x3b3;-producing T<sub>H</sub>1 cells and M1 type macrophages, and an increased number of CD4<sup>+</sup>IL-4<sup>+</sup> T cells (<xref ref-type="bibr" rid="B12">Feng et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B48">Shang et&#xa0;al., 2011b</xref>; <xref ref-type="bibr" rid="B46">Shaler et&#xa0;al., 2013</xref>). However, less is even known about how CS may affect the immunosuppressive cells such as Tregs in the context of TB.</p>
<p>Tregs are specialized CD4<sup>+</sup> T cells that develop from na&#xef;ve T cells in the presence of TFG&#x3b2;. In turn, Tregs produce anti-inflammatory cytokines TGF&#x3b2;, IL-35 and IL-10 (<xref ref-type="bibr" rid="B57">Vignali et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B51">Shevach, 2009</xref>; <xref ref-type="bibr" rid="B9">Cavassani et&#xa0;al., 2010</xref>) although a subset of Tregs (FrIII) is known to secrete IFN&#x3b3; and IL-2 (<xref ref-type="bibr" rid="B34">Miyara et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B40">Qiu et&#xa0;al., 2017</xref>). Through the anti-inflammatory cytokines, Tregs can suppress anti-TB immunity during the early stages of infection (<xref ref-type="bibr" rid="B36">Ordway et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B45">Shafiani et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B47">Shang et&#xa0;al., 2011a</xref>; <xref ref-type="bibr" rid="B26">Larson et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B44">Semple et&#xa0;al., 2013</xref>). Another immunosuppressive mechanism of Tregs is their ability to inhibit T effector cells, partly through the secretion of granzyme B, which breaches the cell walls of T effector cells, causing them to undergo apoptosis in a perforin-dependent fashion (<xref ref-type="bibr" rid="B14">Grossman et&#xa0;al., 2004</xref>). Tregs may also suppress M1 macrophage activation and induce macrophage differentiation to the M2 phenotype (<xref ref-type="bibr" rid="B54">Tiemessen et&#xa0;al., 2007</xref>; <xref ref-type="bibr" rid="B30">Martinez et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B51">Shevach, 2009</xref>). M2 macrophages exhibit impaired induction of pro-inflammatory cytokines and macrophage effector functions against <italic>MTB</italic> such as P-L fusion, autophagy, and apoptosis (<xref ref-type="bibr" rid="B33">Mills, 2012</xref>; <xref ref-type="bibr" rid="B41">Romano et&#xa0;al., 2018</xref>). In addition, the cell surface protein LAG3 on Tregs binds to MHCII on DC, preventing further DC activation (<xref ref-type="bibr" rid="B28">Liang et&#xa0;al., 2008</xref>). The surface protein TIGIT found on T effector cells and Tregs also binds DC causing secretion of TGF&#x3b2; and IL-10, immunosuppressive cytokines capable of inhibiting T effector cells and DC (<xref ref-type="bibr" rid="B66">Yu et&#xa0;al., 2009</xref>). However, Tregs may also be necessary at the latter stages of infection when <italic>MTB</italic> comes under control to prevent inflammatory tissue damage that may occur, with the injury contributed by an excessive response of CD4<sup>+</sup>IFN&#x3b3;<sup>+</sup> T cells (<xref ref-type="bibr" rid="B25">Kumar, 2017</xref>; <xref ref-type="bibr" rid="B8">Cardona and Cardona, 2019</xref>).</p>
<p>CS and nicotine are also known to increase the activation or production of Tregs (<xref ref-type="bibr" rid="B32">M&#xe9;nard and Rola-Pleszczynski, 1987</xref>; <xref ref-type="bibr" rid="B4">Barcel&#xf3; et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B7">Botelho et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B63">Wang et&#xa0;al., 2010</xref>). Using primary murine cells, we previously demonstrated that nicotine-exposed Tregs impaired murine macrophages from controlling an <italic>ex vivo MTB</italic> infection (<xref ref-type="bibr" rid="B3">Bai et&#xa0;al., 2017</xref>). This current study revealed that CS exposure of <italic>only</italic> primary human Tregs followed by their co-culture with unexposed macrophages enhances proliferation of <italic>MTB</italic> in the macrophages by inhibiting both P-L fusion and autophagosome formation/maturation.</p>
<p>While rapamycin is known to increase autophagosome formation by inhibiting mTOR, it could also indirectly drive autophagosome degradation &#x2013; analogous to LeChatelier&#x2019;s principle with chemical reactions by providing an increased number of the substrate (autophagosomes). Thus, if rapamycin-induced autophagosome degradation rate is greater than rapamycin-induced autophagosome formation rate and combined with decreased autophagosome formation due to the CS extract-exposed Tregs, one may not see an increase in autophagosomes with rapamycin and in fact may see a modest decrease, which is what was observed (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A, B</bold>
</xref>). These pathways are made more complex by the finding that rapamycin can also increase p62 mRNA and protein expression in an autophagy independent pathway (<xref ref-type="bibr" rid="B22">Ko et&#xa0;al., 2017</xref>). We also found that in the presence of bafilomycin, an inhibitor of autophagosome-lysosome fusion, there was no significant difference in the total p62(+) puncta, which would be an expected finding if an increase in p62(+) puncta due to bafilomycin was countered by decreased autophagosome formation from the CS extract-exposed Tregs. We conclude from these autophagy experiments that CS extract-exposed Tregs reduce autophagosome formation in macrophages and that this reduction prevailed over the decrease in autophagosome maturation.</p>
<p>One molecular mechanism for the increased Treg activity with CS or nicotine exposure is induction of CTLA-4 and PD-L1, the latter a ligand for PD-1 (<xref ref-type="bibr" rid="B67">Zhang and Petro, 1996</xref>; <xref ref-type="bibr" rid="B64">Wing et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B13">Francisco et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B65">Yanagita et&#xa0;al., 2012</xref>). While engagements of CTLA-4 and PD-1 to their respective ligands deactivate effector T cells, they enhance Treg function, as supported by the observation that blockade of CTLA-4 and PD-1 are known to exacerbate autoimmune diseases through deactivation of Tregs (<xref ref-type="bibr" rid="B58">Walker, 2013</xref>; <xref ref-type="bibr" rid="B24">Kong and Flynn, 2014</xref>). But in human Tregs, we did not find an increase in the number of PD-1 positive Tregs but rather an increase in CTLA-4 positive Tregs with CS extract exposure. We further showed that CS induction of CTLA-4 on Tregs is a mechanism by which CS-exposed Tregs impair macrophage control of <italic>MTB</italic> infection.</p>
<p>The murine adoptive transfer studies corroborated the <italic>in vitro</italic> human cell data in that recipient Thy1.2 mice that received Tregs from donor CS-exposed mice had increased <italic>MTB</italic> burden in both the lungs and spleens compared to the two murine controls (<italic>MTB</italic> infection of na&#xef;ve mice and of mice that received Tregs from air-exposed mice). Interestingly, the increase in CFU of the mice that received Tregs from CS-exposed mice was not observed until Day 60 in the lungs and spleens. While there was a significant increase in CFU with mice that received Tregs from CS-exposed mice in the spleen at Day 30, it was by ~one-half log of CFU increase.</p>
<p>The increased <italic>MTB</italic> burden in the lungs and spleens of the mice that received Tregs from CS-exposed mice was not due to increased number of Tregs (<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>), indicating conceivably that CS exposure of Tregs increased their immunosuppressive activity, consistent with prior studies showing that CS and nicotine may increase the influx and function of Tregs in the lungs (<xref ref-type="bibr" rid="B32">M&#xe9;nard and Rola-Pleszczynski, 1987</xref>; <xref ref-type="bibr" rid="B4">Barcel&#xf3; et&#xa0;al., 2008</xref>; <xref ref-type="bibr" rid="B7">Botelho et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B63">Wang et&#xa0;al., 2010</xref>). Hence, compared to the two <italic>MTB</italic>-infected mouse control groups, the increased CFU seen in mice that received Tregs from CS-exposed mice may be due to the following immunophenotypic findings: significant decrease in IL-12<sup>+</sup> DC, an increase in CTLA-4<sup>+</sup> macrophages, and an increase in CD4<sup>+</sup>PD-1<sup>+</sup> T cells and a trend toward increased IL-10<sup>+</sup> macrophages and decreased TNF<sup>+</sup> lung macrophages, IL-12<sup>+</sup> macrophages, and total IFN&#x3b3;<sup>+</sup>CD4<sup>+</sup> T cells and Thy1.1<sup>+</sup>CD4<sup>+</sup>IFN&#x3b3;<sup>+</sup> transferred Tregs. However, in recipient mice that received Tregs from donor CS-exposed mice, we found fewer CTLA-4<sup>+</sup> DC. CTLA-4 has been previously reported on macrophages (<xref ref-type="bibr" rid="B19">Hua et&#xa0;al., 1999</xref>; <xref ref-type="bibr" rid="B62">Wang et&#xa0;al., 2002</xref>) and dendritic cells (<xref ref-type="bibr" rid="B61">Wang et&#xa0;al., 2011</xref>) and may play a role in inhibiting immune response. Thus, this finding seems paradoxical since fewer CTLA-4<sup>+</sup> DC would be expected not to inhibit CD4<sup>+</sup> T effector cell as much, and thus would have relatively greater host immunity against <italic>MTB</italic> (<xref ref-type="bibr" rid="B27">Laurent et&#xa0;al., 2010</xref>).</p>
<p>The observed reduction in IFN&#x3b3;<sup>+</sup> T cells in mice that received Tregs from CS-exposed donor mice would be expected to reduce macrophage activation and MHCII expression. Since a subset of Tregs can also produce IFN&#x3b3; (<xref ref-type="bibr" rid="B34">Miyara et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B68">Zhao et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B23">Koenecke et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B53">Sumida et&#xa0;al., 2018</xref>), it is interesting to note that mice that received Tregs from either air- or CS-exposed mice had similar number of donor (Thy1.1) IFN&#x3b3;<sup>+</sup> Tregs at Days 1 and 30 after infection, and yet mice that received Tregs from CS-exposed mice had decreased number of donor IFN&#x3b3;<sup>+</sup> Tregs at Day 60 compared to those that received Tregs from air-exposed mice (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9E</bold>
</xref>). While we did not directly examine the three subpopulations of Tregs, this finding would suggest that CS exposure &#x2013; in a delayed fashion and following <italic>MTB</italic> infection &#x2013; resulted in a decrease in the number of pro-inflammatory, cytokine-producing (FrIII) Treg subpopulation (<xref ref-type="bibr" rid="B34">Miyara et&#xa0;al., 2009</xref>). In a recent review of Tregs and <italic>MTB</italic> infection, no mention was made regarding the three subpopulations of Tregs although they alluded to another type of activated, immunosuppressive Tregs (CD4<sup>+</sup>CD25<sup>hi</sup>CD39<sup>+</sup>) (<xref ref-type="bibr" rid="B8">Cardona and Cardona, 2019</xref>). Mice that received air-exposed Tregs had fewer CD4<sup>+</sup>IL-1<sup>+</sup> T cells than those that received Tregs from CS-exposed mice; this finding was somewhat unexpected since IL-1 is generally considered host-protective.</p>
<p>There are several limitations to this study although we do not believe they detract from the key finding that CS-exposed Tregs impair host-immunity against <italic>MTB</italic>. Firstly, cytokine levels were not measured in unexposed and CS extract-exposed human Tregs alone, which would help determine the contribution of Tregs vs. MDM in cytokine expression in response to CS. However, because Tregs are not known to phagocytose <italic>MTB</italic>, the significance of cytokine expression of CS-exposed Tregs alone (in the absence of <italic>MTB</italic>-infected macrophages) would be difficult to interpret. Secondly, since we did not see a difference in PD-1 or CTLA-4 expression of the donor Thy1.1<sup>+</sup> Tregs in the lungs of the recipient mice, another limitation of the study is that we did not quantify Tim3 expression in these Tregs as Tim3 is increased in smokers and is increasingly recognized as an exhaustion marker for T effector cells (<xref ref-type="bibr" rid="B55">Valiathan et&#xa0;al., 2014</xref>) and thus could be an activation marker for Tregs &#x2013; as has been described for PD-1 and CTLA-4. Thirdly, we did not examine separately the three subpopulations of Tregs in either the human co-culture with macrophages or the murine adoptive transfer studies; however, such approaches would be extremely challenging technically with the likely possibility that not enough Tregs of each subpopulation would be able to be isolated for the required experiments. Fourthly, we used CS extract for the <italic>ex vivo</italic> human cell experiments and whole CS for the <italic>in vivo</italic> studies. While both human cell and murine adoptive studies showed similar relative CFU findings with CS extract- vs. whole CS-exposed Tregs, some differences were observed in the ancillary findings; <italic>e.g.</italic>, whereas unexposed Tregs + macrophages and especially CS-exposed Tregs + macrophages produced significantly more IL-10 than macrophages alone in the human cell studies (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4B</bold>
</xref>, <xref ref-type="fig" rid="f5">
<bold>5D</bold>
</xref>), there was a decrease in IL-10<sup>+</sup> macrophages at Day 60 after infection in mice that received Tregs from either unexposed or CS-exposed donor mice (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>). While such differences may be due to multiple factors, one possible reason is the difference in CS product used in the human cell (CS extract) and murine adoptive transfer (whole CS) studies. Fifthly, we used two different strains of <italic>MTB</italic>, H37Rv-<italic>MTB</italic> for the <italic>ex vivo</italic> human cell experiments and <italic>HN878-W-Beijing MTB</italic> for the <italic>in vivo</italic> mouse investigations. Thus, it would be interesting to compare laboratory and clinical <italic>MTB</italic> strains in future studies for each set of experiments.</p>
<p>In conclusion, we found that CS extract-exposed Tregs or Tregs from CS-exposed mice plays an active role in impairing human macrophage and mouse immunity, respectively, against <italic>MTB</italic>. Mice that received Tregs from CS exposed mice were also more compromised in controlling <italic>MTB</italic> infection due mainly to a decrease in both host-protective effector innate and T cell phenotypes. In primary human cells, CS extract-exposed Tregs impaired macrophage control of <italic>MTB</italic> by inhibiting P-L fusion and autophagosome formation and to a lesser extent by inhibiting autophagosome maturation.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="s11">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The studies involving humans were approved by COMIRB (University of Colorado Anschutz Medical Campus) and IRB (National Jewish Health) for Human Subjects. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. The animal study was approved by ACORP (Rocky Mountain Regional VA Medical Center) &amp; IACUC (National Jewish Health) for Animals. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>XB, DO, and EC conceived the study. XB, DV, LL, NW, JG, TO, and DO conducted the murine experiments and analyzed the data. CG, AM, KK, LF, ME, and MG were responsible for the human cell studies. All authors contributed to the intellectual input, writing, editing, and approving the manuscript.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Veterans Affairs, Veterans Health Administration, Office of Research and Development grant 1 I01 CX001452-01A1, for which we are grateful.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2023.1216492/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2023.1216492/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.pdf" id="SF1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Honda</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Eichstaedt</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Musheyev</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Alpha-1-antitrypsin enhances primary human macrophage immunity against non-tuberculous mycobacteria</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <elocation-id>1417</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.01417</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Henao-Tamayo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Basaraba</surname> <given-names>R. J.</given-names>
</name>
<name>
<surname>Ovrutsky</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Matsuda</surname> <given-names>J. L.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Human IL-32 expression protects mice against a hypervirulent strain of <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>112</volume>, <fpage>5111</fpage>&#x2013;<lpage>5116</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1424302112</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bai</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Stitzel</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zambrano</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Marrack</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Nicotine impairs macrophage control of <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source> <volume>57</volume>, <fpage>324</fpage>&#x2013;<lpage>333</lpage>. doi: <pub-id pub-id-type="doi">10.1165/rcmb.2016-0270OC</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barcel&#xf3;</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Pons</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Ferrer</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Sauleda</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fuster</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Agust&#xed;</surname> <given-names>A. G.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking</article-title>. <source>Eur. Respir. J.</source> <volume>31</volume>, <fpage>555</fpage>&#x2013;<lpage>562</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09031936.00010407</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bishwakarma</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kinney</surname> <given-names>W. H.</given-names>
</name>
<name>
<surname>Honda</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Mya</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Strand</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Gangavelli</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Epidemiologic link between tuberculosis and cigarette/biomass smoke exposure: Limitations despite the vast literature</article-title>. <source>Respirology</source> <volume>20</volume>, <fpage>556</fpage>&#x2013;<lpage>568</lpage>. doi: <pub-id pub-id-type="doi">10.1111/resp.12515</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boer</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Joosten</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Ottenhoff</surname> <given-names>T. H.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination</article-title>. <source>Front. Immunol.</source> <volume>6</volume>, <elocation-id>217</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2015.00217</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botelho</surname> <given-names>F. M.</given-names>
</name>
<name>
<surname>Gaschler</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Kianpout</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zavitz</surname> <given-names>C. C. J.</given-names>
</name>
<name>
<surname>Trimble</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Nikota</surname> <given-names>J. K.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Innate immune processes are sufficient for driving cigarette smoke-induced inflammation in mice</article-title>. <source>Am. J. Respir. Cell Mol. Biol.</source> <volume>42</volume>, <fpage>394</fpage>&#x2013;<lpage>403</lpage>. doi: <pub-id pub-id-type="doi">10.1165/rcmb.2008-0301OC</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cardona</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Cardona</surname> <given-names>P.-J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Regulatory T cells in <italic>mycobacterium tuberculosis</italic> infection</article-title>. <source>Front. Immunol.</source> <volume>10</volume>, <elocation-id>2139</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.02139</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavassani</surname> <given-names>K. A.</given-names>
</name>
<name>
<surname>Carson</surname> <given-names>W. F.</given-names>
</name>
<name>
<surname>Moreira</surname> <given-names>A. P.</given-names>
</name>
<name>
<surname>Wen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Schaller</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Ishii</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth</article-title>. <source>Blood</source> <volume>115</volume>, <fpage>4403</fpage>&#x2013;<lpage>4411</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1182/blood-2009-09-241083</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname> <given-names>E. D.</given-names>
</name>
<name>
<surname>Kinney</surname> <given-names>W. H.</given-names>
</name>
<name>
<surname>Honda</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Bishwakarma</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Gangavelli</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Mya</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Tobacco exposure and susceptibility to tuberculosis: is there a smoking gun</article-title>? <source>Tuberculosis (Edinb)</source> <volume>94</volume>, <fpage>544</fpage>&#x2013;<lpage>550</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tube.2014.08.010</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiang</surname> <given-names>C.-Y.</given-names>
</name>
<name>
<surname>Bam</surname> <given-names>T. S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The impact of smoking on TB treatment outcomes includes recurrent TB</article-title>. <source>Int. J. Tuberc Lung Dis.</source> <volume>24</volume>, <fpage>1224</fpage>&#x2013;<lpage>1225</lpage>. doi: <pub-id pub-id-type="doi">10.5588/ijtld.20.0411</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Barnes</surname> <given-names>P. F.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>F. F.</given-names>
</name>
<name>
<surname>Klucar</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Exposure to cigarette smoke inhibits the pulmonary T-cell response to influenza virus and <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Infect. Immun.</source> <volume>79</volume>, <fpage>229</fpage>&#x2013;<lpage>237</lpage>. doi: <pub-id pub-id-type="doi">10.1128/IAI.00709-10</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Francisco</surname> <given-names>L. M.</given-names>
</name>
<name>
<surname>Sage</surname> <given-names>P. T.</given-names>
</name>
<name>
<surname>Sharpe</surname> <given-names>A. H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The PD-1 pathway in tolerance and autoimmunity</article-title>. <source>Immunol. Rev.</source> <volume>236</volume>, <fpage>219</fpage>&#x2013;<lpage>242</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1600-065X.2010.00923.x</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grossman</surname> <given-names>W. J.</given-names>
</name>
<name>
<surname>Verbsky</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Barchet</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Colonna</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Atkinson</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Ley</surname> <given-names>T. J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Human T regulatory cells can use the perforin pathway to cause autologous target cell death</article-title>. <source>Immunity</source> <volume>21</volume>, <fpage>589</fpage>&#x2013;<lpage>601</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2004.09.002</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="web">
<person-group person-group-type="author">
<name>
<surname>Hammond</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>) <source>Measuring cell fluorescence using ImageJ</source>. Available at: <uri xlink:href="https://theolb.readthedocs.io/en/latest/imaging/measuring-cell-fluorescence-using-imagej.html">https://theolb.readthedocs.io/en/latest/imaging/measuring-cell-fluorescence-using-imagej.html</uri>.</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henao-Tamayo</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Obreg&#xf3;n-Henao</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Arnett</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Shanley</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Podell</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Orme</surname> <given-names>I. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Effect of bacillus calmette-gu&#xe9;rin vaccination on CD4+Foxp3+ T cells during acquired immune response to <italic>mycobacterium tuberculosis</italic> infection</article-title>. <source>J. Leukoc. Biol.</source> <volume>99</volume>, <fpage>605</fpage>&#x2013;<lpage>617</lpage>. doi: <pub-id pub-id-type="doi">10.1189/jlb.4A0614-308RR</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henao-Tamayo</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>Ordway</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Irwin</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shanley</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Orme</surname> <given-names>I. M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Clin. Vaccine Immunol.</source> <volume>17</volume>, <fpage>618</fpage>&#x2013;<lpage>625</lpage>. doi: <pub-id pub-id-type="doi">10.1128/CVI.00368-09</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heron</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Grutters</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>ten Dam-Molenkamp</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Hijdra</surname> <given-names>D.</given-names>
</name>
<name>
<surname>van Heugten-Roeling</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Cleassen</surname> <given-names>A. M. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Bronchoalveolar lavage cell pattern from healthy human lung</article-title>. <source>Clin. Exp. Immunol.</source> <volume>167</volume>, <fpage>523</fpage>&#x2013;<lpage>553</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2249.2011.04529.x</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hua</surname> <given-names>G. Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Takagi</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Shimozato</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Yagita</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Okigaki</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>1999</year>). <article-title>Expression of a soluble form of CTLA4 on macrophage and its biological activity</article-title>. <source>Cell Res.</source> <volume>9</volume>, <fpage>189</fpage>&#x2013;<lpage>199</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.cr.7290017</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Z.-Z.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>S.-C.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Cigarette smoke extract promotes DNA methyltransferase 3a expression in dendritic cells, inducing Th-17/Treg imbalance via the c-Jun/allograft inflammatory factor 1 axis</article-title>. <source>Kaohsiung J. Med. Sci.</source> <volume>37</volume>, <fpage>594</fpage>&#x2013;<lpage>603</lpage>. doi: <pub-id pub-id-type="doi">10.1002/kjm2.12367</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Isajevs</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Taivans</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Strazda</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Kopeika</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Bukovskis</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gordjusina</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Decreased FOXP3 expression in small airways of smokers with COPD</article-title>. <source>Eur. Respir. J.</source> <volume>33</volume>, <fpage>61</fpage>&#x2013;<lpage>67</lpage>. doi: <pub-id pub-id-type="doi">10.1183/09031936.00145307</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ko</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Yoon</surname> <given-names>S. O.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>H. J.</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>J. Y.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Rapamycin regulates macrophage activation by inhibiting NLRP3 inflammasome-p38 MAPK-NF&#x3ba;B pathways in autophagy- and p62-dependent manners</article-title>. <source>Oncotarget</source> <volume>8</volume>, <fpage>40817</fpage>&#x2013;<lpage>40831</lpage>. doi: <pub-id pub-id-type="doi">10.18632/oncotarget.17256</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koenecke</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Thamm</surname> <given-names>K.</given-names>
</name>
<name>
<surname>F&#xf6;hse</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Schafferus</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mittr&#xfc;cker</surname> <given-names>H. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>IFN-&#x3b3; production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease</article-title>. <source>J. Immunol.</source> <volume>189</volume>, <fpage>2890</fpage>&#x2013;<lpage>2896</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1200413</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kong</surname> <given-names>Y. M.</given-names>
</name>
<name>
<surname>Flynn</surname> <given-names>J. C.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Opportunistic autoimmune disorders potentiated by immune-checkpoint inhibitors anti-CTLA-4 and anti-PD-1</article-title>. <source>Front. Immunol.</source> <volume>5</volume>, <elocation-id>206</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2014.00206</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>IFN&#x3b3;-producing CD4 + T lymphocytes: the double-edged swords in tuberculosis</article-title>. <source>Clin. Transl. Med.</source> <volume>6</volume>, <fpage>21</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40169-017-0151-8</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Larson</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Shafiani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Urdahl</surname> <given-names>K. B.</given-names>
</name>
</person-group> (<year>2013</year>). &#x201c;<article-title>Foxp3+ regulatory T cells in tuberculosis</article-title>,&#x201d; in <source>The New Paradigm of Immunity to Tuberculosis</source>. Ed. <person-group person-group-type="editor">
<name>
<surname>Divangahi</surname> <given-names>M.</given-names>
</name>
</person-group> (<publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>165</fpage>&#x2013;<lpage>180</lpage>.</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laurent</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Carrega</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Saverino</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Piccioli</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Camoriano</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Morabito</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions</article-title>. <source>Hum. Immunol.</source> <volume>71</volume>, <fpage>934</fpage>&#x2013;<lpage>941</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.humimm.2010.07.007</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Workman</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chew</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Dale</surname> <given-names>B. M.</given-names>
</name>
<name>
<surname>Colonna</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II</article-title>. <source>J. Immunol.</source> <volume>180</volume>, <fpage>5916</fpage>&#x2013;<lpage>5926</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.180.9.5916</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machicote</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Bel&#xe9;n</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Baz</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Billordo</surname> <given-names>L. A.</given-names>
</name>
<name>
<surname>Fainboim</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Human CD8+ HLA-DR+ Regulatory T cells, similarly to classical CD4+ Foxp3+ Cells, suppress immune responses via PD-1/PD-L1 axis</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <elocation-id>2788</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.02788</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname> <given-names>F. O.</given-names>
</name>
<name>
<surname>Helming</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Gordon</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Alternative activation of macrophages: an immunologic functional perspective</article-title>. <source>Annu. Rev. Immunol.</source> <volume>27</volume>, <fpage>451</fpage>&#x2013;<lpage>483</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev.immunol.021908.132532</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mauvezin</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Neufeld</surname> <given-names>T. P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and ca-P60A/SERCA-dependent autophagosome-lysosome fusion</article-title>. <source>Autophagy</source> <volume>11</volume>, <fpage>1437</fpage>&#x2013;<lpage>1438</lpage>. doi: <pub-id pub-id-type="doi">10.1080/15548627.2015.1066957</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>M&#xe9;nard</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Rola-Pleszczynski</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>Nicotine induces T-suppressor cells: modulation by the nicotinic antagonist D-tubocurarine and myasthenic serum</article-title>. <source>Clin. Immunol. Immunopathol.</source> <volume>44</volume>, <fpage>107</fpage>&#x2013;<lpage>113</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0090-1229(87)90056-0</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mills</surname> <given-names>C. D.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>M1 and M2 macrophages: oracles of health and disease</article-title>. <source>Crit. Rev. Immunol.</source> <volume>32</volume>, <fpage>463</fpage>&#x2013;<lpage>488</lpage>. doi: <pub-id pub-id-type="doi">10.1615/CritRevImmunol.v32.i6.10</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miyara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yoshioka</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kitoh</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Shima</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Wing</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Niwa</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor</article-title>. <source>Immunity</source> <volume>30</volume>, <fpage>899</fpage>&#x2013;<lpage>911</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2009.03.019</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Leary</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Coleman</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Chew</surname> <given-names>W. M.</given-names>
</name>
<name>
<surname>Morrow</surname> <given-names>C.</given-names>
</name>
<name>
<surname>McLaughlin</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Gleeson</surname> <given-names>L. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Cigarette smoking impairs human pulmonary immunity to <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>190</volume>, <fpage>1430</fpage>&#x2013;<lpage>1436</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201407-1385OC</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ordway</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Henao-Tamayo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Harton</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Palanisamy</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Troudt</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Shanley</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>The hypervirulent <italic>Mycobacterium tuberculosis</italic> strain HN878 induces a potent TH1 response followed by rapid down-regulation</article-title>. <source>J. Immunol.</source> <volume>179</volume>, <fpage>522</fpage>&#x2013;<lpage>531</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.179.1.522</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouyang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Virasch</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Aubrey</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Mukerjee</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Bierer</surname> <given-names>B. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2000</year>). <article-title>Suppression of human IL-1beta, IL-2, IFN-gamma, and TNF-alpha production by cigarette smoke extracts</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>106</volume>, <fpage>280</fpage>&#x2013;<lpage>287</lpage>. doi: <pub-id pub-id-type="doi">10.1067/mai.2000.107751</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozeki</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Sugawara</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Udagawa</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Aoki</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Osada-Oka</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tateishi</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice</article-title>. <source>Int. Immunol.</source> <volume>22</volume>, <fpage>179</fpage>&#x2013;<lpage>189</lpage>. doi: <pub-id pub-id-type="doi">10.1093/intimm/dxp126</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pai</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Mohan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dheda</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>C. C.</given-names>
</name>
<name>
<surname>Yew</surname> <given-names>W. W.</given-names>
</name>
<name>
<surname>Christopher</surname> <given-names>D. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2007</year>). <article-title>Lethal interaction: the colliding epidemics of tobacco and tuberculosis</article-title>. <source>Expert Rev. Anti Infect. Ther.</source> <volume>5</volume>, <fpage>385</fpage>&#x2013;<lpage>391</lpage>. doi: <pub-id pub-id-type="doi">10.1586/14787210.5.3.385</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qiu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>C. L.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Y. Q.</given-names>
</name>
<name>
<surname>Hou</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Impacts of cigarette smoking on immune responsiveness: Up and down or upside down</article-title>? <source>Oncotarget</source> <volume>8</volume>, <fpage>268</fpage>&#x2013;<lpage>284</lpage>. doi: <pub-id pub-id-type="doi">10.18632/oncotarget.13613</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Romano</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fanelli</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Nova-Lamperti</surname> <given-names>E.</given-names>
</name>
<name>
<surname>McGregor</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Lechler</surname> <given-names>R. I.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Expanded regulatory T cells induce alternatively activated monocytes with a reduced capacity to expand T helper-17 cells</article-title>. <source>Front. Immunol.</source> <volume>9</volume>, <elocation-id>1625</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2018.01625</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rowe</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Ertelt</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Way</surname> <given-names>S. S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Foxp3(+) regulatory T cells, immune stimulation and host defence against infection</article-title>. <source>Immunology</source> <volume>136</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1365-2567.2011.03551.x</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saresella</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Marventano</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Longhi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Lissoni</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Trabattoni</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Mendozzi</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy</article-title>. <source>FASEB J.</source> <volume>22</volume>, <fpage>3500</fpage>&#x2013;<lpage>3508</lpage>. doi: <pub-id pub-id-type="doi">10.1096/fj.08-110650</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Semple</surname> <given-names>P. L.</given-names>
</name>
<name>
<surname>Binder</surname> <given-names>A. B.</given-names>
</name>
<name>
<surname>Davids</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Maredza</surname> <given-names>A.</given-names>
</name>
<name>
<surname>van Zyl-Smit</surname> <given-names>R. N.</given-names>
</name>
<name>
<surname>Dheda</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Regulatory T-cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with TB</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>187</volume>, <fpage>1249</fpage>&#x2013;<lpage>1258</lpage>. doi: <pub-id pub-id-type="doi">10.1164/rccm.201210-1934OC</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shafiani</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tucker-Heard</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Kariyone</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Takatsu</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Urdahl</surname> <given-names>K. B.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis</article-title>. <source>J. Exp. Med.</source> <volume>207</volume>, <fpage>1409</fpage>&#x2013;<lpage>1420</lpage>. doi: <pub-id pub-id-type="doi">10.1084/jem.20091885</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaler</surname> <given-names>C. R.</given-names>
</name>
<name>
<surname>Horvath</surname> <given-names>C. N.</given-names>
</name>
<name>
<surname>McCormick</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jeyanathan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Khera</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zganiacz</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>Continuous and discontinuous cigarette smoke exposure differentially affects protective Th1 immunity against pulmonary tuberculosis</article-title>. <source>PloS One</source> <volume>8</volume>, <elocation-id>e59185</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0059185</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Harton</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Tamayo</surname> <given-names>M. H.</given-names>
</name>
<name>
<surname>Shanley</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Palansamy</surname> <given-names>G. S.</given-names>
</name>
<name>
<surname>Caraway</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>a). <article-title>Increased Foxp3 expression in Guinea pigs infected with W-Beijing strains of <italic>M. tuberculosis</italic>
</article-title>. <source>Tuberculosis</source> <volume>91</volume>, <fpage>378</fpage>&#x2013;<lpage>385</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.tube.2011.06.001</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ordway</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Henao-Tamayo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Oberley-Deegan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Shanley</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>b). <article-title>Cigarette smoke increases susceptibility to tuberculosis &#x2013; evidence from in <italic>vivo</italic> and in <italic>vitro</italic> models</article-title>. <source>J. Infect. Dis.</source> <volume>203</volume>, <fpage>1240</fpage>&#x2013;<lpage>1248</lpage>. doi: <pub-id pub-id-type="doi">10.1093/infdis/jir009</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Cornwell</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kirchhoff</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Saasoud</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Chronic exposure to the combination of cigarette smoke and morphine decreases CD4+ Regulatory T cell numbers by reprogramming the treg cell transcriptome</article-title>. <source>Front. Immunol.</source> <volume>13</volume>, <elocation-id>887681</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2022.887681</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaykhiev</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Krause</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Salit</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Strulovici-Barel</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Harvey</surname> <given-names>B. G.</given-names>
</name>
<name>
<surname>O&#x2019;Connor</surname> <given-names>T. P.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease</article-title>. <source>J. Immunol.</source> <volume>183</volume>, <fpage>2867</fpage>&#x2013;<lpage>2883</lpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.0900473</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shevach</surname> <given-names>E. M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Mechanisms of Foxp3+ T regulatory cell-mediated suppression</article-title>. <source>Immunity</source> <volume>30</volume>, <fpage>636</fpage>&#x2013;<lpage>645</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2009.04.010</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smyth</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Starkey</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Vestbo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>CD4-regulatory cells in COPD patients</article-title>. <source>Chest</source> <volume>132</volume>, <fpage>156</fpage>&#x2013;<lpage>163</lpage>. doi: <pub-id pub-id-type="doi">10.1378/chest.07-0083</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sumida</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Lincoln</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Ukeje</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Rodriguez</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>Akazawa</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Noda</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Activated beta-catenin in Foxp3(+) regulatory T cells links inflammatory environments to autoimmunity</article-title>. <source>Nat. Immunol.</source> <volume>19</volume>, <fpage>1391</fpage>&#x2013;<lpage>1402</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41590-018-0236-6</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiemessen</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Jagger</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>H. G.</given-names>
</name>
<name>
<surname>van Herwijnen</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>John</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Taams</surname> <given-names>L. S.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>104</volume>, <fpage>19446</fpage>&#x2013;<lpage>19451</lpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0706832104</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valiathan</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Miguez</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Patel</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Arheart</surname> <given-names>K. L.</given-names>
</name>
<name>
<surname>Asthana</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study</article-title>. <source>PloS One</source> <volume>9</volume>, <elocation-id>e97698</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0097698</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Zyl-Smit</surname> <given-names>R. N.</given-names>
</name>
<name>
<surname>Binder</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Meldau</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Semple</surname> <given-names>P. L.</given-names>
</name>
<name>
<surname>Evans</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Cigarette smoke impairs cytokine responses and BCG containment in alveolar macrophages</article-title>. <source>Thorax</source> <volume>69</volume>, <fpage>363</fpage>&#x2013;<lpage>370</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thoraxjnl-2013-204229</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vignali</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Collison</surname> <given-names>L. W.</given-names>
</name>
<name>
<surname>Workman</surname> <given-names>C. J.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>How regulatory T cells work</article-title>. <source>Nat. Rev. Immunol.</source> <volume>8</volume>, <fpage>523</fpage>&#x2013;<lpage>532</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nri2343</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walker</surname> <given-names>L. S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Treg and CTLA-4: two intertwining pathways to immune tolerance</article-title>. <source>J. Autoimmun</source> <volume>45</volume>, <fpage>49</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaut.2013.06.006</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wallace</surname> <given-names>W. A.</given-names>
</name>
<name>
<surname>Gillooly</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lamb</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Intra-alveolar macrophage numbers in current smokers and non-smokers: a morphometric study of tissue sections</article-title>. <source>Thorax</source> <volume>47</volume>, <fpage>437</fpage>&#x2013;<lpage>440</lpage>. doi: <pub-id pub-id-type="doi">10.1136/thx.47.6.437</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>E. Y.</given-names>
</name>
<name>
<surname>Arrazola</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Mathema</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Ahluwalia</surname> <given-names>I. B.</given-names>
</name>
<name>
<surname>Mase</surname> <given-names>S. R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The impact of smoking on tuberculosis treatment outcomes: a meta-analysis</article-title>. <source>Int. J. Tuberc Lung Dis.</source> <volume>24</volume>, <fpage>170</fpage>&#x2013;<lpage>175</lpage>. doi: <pub-id pub-id-type="doi">10.5588/ijtld.19.0002</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X. B.</given-names>
</name>
<name>
<surname>Fan</surname> <given-names>Z. Z.</given-names>
</name>
<name>
<surname>Anton</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Vollenhoven</surname> <given-names>A. V.</given-names>
</name>
<name>
<surname>Ni</surname> <given-names>Z. H.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>X. F.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation</article-title>. <source>BMC Immunol.</source> <volume>12</volume>, <fpage>21</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2172-12-21</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X. B.</given-names>
</name>
<name>
<surname>Giscombe</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Heiden</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lefvert</surname> <given-names>A. K.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Expression of CTLA-4 by human monocytes</article-title>. <source>Scand. J. Immunol.</source> <volume>55</volume>, <fpage>53</fpage>&#x2013;<lpage>60</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.0300-9475.2001.01019.x</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>D. W.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>R. B.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>Y. M.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>X. M.</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Y. M.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>G. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>Stimulation of &#x3b1;7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in <italic>vitro</italic>
</article-title>. <source>J.&#xa0;Pharmacol. Exp. Ther.</source> <volume>335</volume>, <fpage>553</fpage>&#x2013;<lpage>561</lpage>. doi: <pub-id pub-id-type="doi">10.1124/jpet.110.169961</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wing</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Onishi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Prieto-Martin</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Yamaguchi</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Miyara</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Fehervari</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>CTLA-4 control over Foxp3+ regulatory T cell function</article-title>. <source>Science</source> <volume>322</volume>, <fpage>271</fpage>&#x2013;<lpage>275</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1160062</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yanagita</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Kojima</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Mori</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Murakami</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Nicotine modulates the immunological function of dendritic cells through peroxisome proliferator-activated receptor-&#x3b3; upregulation</article-title>. <source>Cell Immunol.</source> <volume>274</volume>, <fpage>26</fpage>&#x2013;<lpage>33</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cellimm.2012.02.007</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Harden</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Gonzalez</surname> <given-names>L. C.</given-names>
</name>
<name>
<surname>Francesco</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Chiang</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Irving</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells</article-title>. <source>Nat. Immunol.</source> <volume>10</volume>, <fpage>48</fpage>&#x2013;<lpage>57</lpage>. doi: <pub-id pub-id-type="doi">10.1038/ni.1674</pub-id>
</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Petro</surname> <given-names>T. M.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>The effect of nicotine on murine CD4 T cell responses</article-title>. <source>Int. J. Immunopharmacol</source> <volume>18</volume>, <fpage>467</fpage>&#x2013;<lpage>478</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0192-0561(96)00054-9</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Fett</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Trandem</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Fleming</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Perlman</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>IFN-&#x3b3;- and IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis</article-title>. <source>J. Exp. Med.</source> <volume>208</volume>, <fpage>1571</fpage>&#x2013;<lpage>1577</lpage>. doi: <pub-id pub-id-type="doi">10.1084/jem.20110236</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>